rfhg_126032.1

Basic information about the TSS

---

TSS ID: rfhg_126032.1 TSS ID(Version3): hg_109686.1 hg_109687.1 Species: human Chr: chr10		Start: 63465969 End: 63466022 Strand: -
Source datasets	FANTOM5|PRJNA4843412|DRA013844
Protocol	CAGE|NETCAGE
TSS cluster detected*	3

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2352032,EH38E1472944)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000399262.7:0 BC067238:0 GeneID: 221037 HGNC/MGI_ID: HGNC:12313 UniProt_ID: Q15652 Nearer transcript ids and distances: EF068222:88 AK027280:123 view more...

Gene_name: jumonji domain containing 1C Gene_symbol: JMJD1C Gene_synonyms: DKFZp761F0118 FLJ14374 KDM3C KIAA1380 Gene_source: HGNC:12313

TATA-Box annotation

---

Distance to TSS:	-18
Nearest PromoterID:	NM_001322252
Entrez ID:	221037
Nearest Unigene:	Hs.413416
Nearest Refseq:	NM_004241
Nearest Ensembl:	ENSG00000171988
Gene Name:	jumonji domain containing 1C
Gene Alias:	KDM3C|TRIP-8|TRIP8
Gene Type:	protein-coding
CpG%:	0.150943
GC%:	0.777778
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@JMJD1C p2@JMJD1C p3@JMJD1C p4@JMJD1C p5@JMJD1C p6@JMJD1C p7@JMJD1C p8@JMJD1C p9@JMJD1C p10@JMJD1C
Sample		p1@JMJD1C	p2@JMJD1C	p3@JMJD1C	p4@JMJD1C	p5@JMJD1C	p6@JMJD1C	p7@JMJD1C	p8@JMJD1C	p9@JMJD1C	p10@JMJD1C
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	8.57	1.36	1.17	3.51	0.00	0.19	0.00	1.75	0.39	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	4.45	1.82	1.42	2.43	0.20	0.40	0.20	2.63	1.01	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	9.07	3.09	2.12	4.44	0.19	0.19	0.00	3.86	0.19	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	6.24	2.70	1.25	1.66	0.00	0.00	0.00	2.08	0.83	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	8.55	1.35	0.67	2.25	0.22	0.67	0.00	0.22	0.22	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	5.62	3.68	2.13	0.97	0.19	0.19	0.00	1.74	0.58	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	7.19	1.96	1.96	3.27	0.44	0.00	0.22	1.96	0.87	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	7.75	1.21	0.48	1.70	0.48	0.48	0.48	1.21	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	4.06	1.28	1.50	1.92	0.00	0.21	0.00	1.07	0.64	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	12.17	4.06	5.80	7.54	0.00	0.00	0.00	1.16	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	10.11	2.83	1.62	8.89	0.81	0.40	0.00	2.43	1.62	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	13.82	2.85	4.47	8.13	0.81	0.41	0.81	1.22	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	8.87	2.90	0.48	0.48	0.00	0.32	0.16	1.77	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	5.86	4.81	1.95	0.15	0.30	0.00	0.15	1.05	0.30	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	10.54	2.20	0.88	0.44	0.44	0.00	0.22	0.66	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	9.05	6.79	1.26	0.25	0.00	0.25	0.50	2.51	1.01	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	9.17	3.49	0.66	0.66	0.44	0.22	0.44	1.09	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	7.59	3.80	0.42	1.27	0.00	0.00	0.00	2.11	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	14.40	9.06	1.07	0.00	0.00	0.53	0.53	2.13	0.53	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	12.19	4.81	1.35	0.30	0.15	0.60	0.30	1.96	0.45	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	12.43	4.28	1.47	0.80	0.27	0.00	0.27	2.14	0.67	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	13.81	5.52	1.73	1.04	0.86	0.17	0.52	1.21	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	16.03	4.91	1.03	0.65	0.13	0.00	0.13	1.55	0.52	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	11.65	3.15	2.18	1.94	0.49	0.24	0.00	0.73	0.73	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	11.09	6.71	1.55	0.52	0.26	0.52	0.26	2.06	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	16.14	6.96	2.53	0.00	0.95	0.32	0.95	0.95	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	16.48	6.59	0.55	1.65	0.55	0.00	0.00	3.30	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	19.33	5.19	3.30	1.18	0.24	0.00	0.00	1.41	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	11.15	6.30	1.78	0.65	0.48	0.16	0.16	3.55	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	14.12	5.97	3.26	1.09	0.18	0.18	0.36	0.90	0.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	16.75	4.19	2.72	1.05	0.21	0.42	0.00	3.56	1.05	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	15.44	4.49	2.15	0.39	0.39	0.39	0.39	2.93	0.78	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	14.35	4.43	2.32	0.63	0.21	0.00	0.42	5.28	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	28.86	9.40	3.63	0.66	0.66	0.16	0.16	2.80	1.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	17.20	4.49	3.37	0.75	1.12	0.37	0.19	2.06	0.93	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	13.41	3.83	2.68	0.38	0.19	0.38	0.00	2.49	0.38	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	9.20	3.88	2.45	0.82	0.20	0.20	0.61	2.25	0.82	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	12.69	3.83	2.62	0.40	0.40	0.40	0.00	1.01	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	11.61	3.51	3.51	1.08	0.54	0.00	0.00	1.89	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	8.64	1.68	2.88	0.00	0.48	0.00	0.00	2.64	0.72	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	7.29	1.65	1.88	1.18	0.71	0.00	0.00	1.65	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	8.49	3.37	1.76	0.59	1.02	0.00	0.00	1.32	0.29	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	6.75	1.69	2.32	0.21	0.21	0.21	0.00	1.05	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	9.44	3.32	1.40	0.87	0.52	0.17	0.17	1.05	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	7.83	3.21	3.41	0.60	0.00	0.20	0.20	1.00	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	7.68	3.26	3.26	0.47	0.47	0.00	0.00	0.23	0.70	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	7.20	2.40	2.40	0.24	0.72	0.48	0.00	1.20	0.48	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	8.64	3.28	2.09	0.30	0.30	0.30	0.00	0.30	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	8.38	4.07	1.91	0.48	0.24	0.24	0.00	0.96	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	9.71	3.24	1.42	0.40	0.00	0.20	0.20	0.40	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	14.14	5.74	3.69	0.61	0.61	0.00	0.00	2.87	0.82	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	10.67	5.78	2.45	0.00	0.67	0.22	0.00	1.33	0.89	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	181.90	69.96	0.00	0.00	13.99	0.00	0.00	0.00	27.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	12.07	5.32	1.77	0.71	0.35	0.00	0.35	3.90	1.06	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	10.60	5.96	1.33	0.00	0.66	0.66	0.00	2.98	1.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	43.62	12.58	10.91	0.00	3.36	0.00	0.00	5.03	1.68	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	14.70	9.18	3.67	0.46	0.92	0.00	0.92	4.59	1.38	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	7.78	5.51	0.97	0.32	0.00	0.00	0.32	2.59	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	5.14	3.85	1.61	0.00	0.00	0.00	0.00	2.57	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	12.89	5.34	2.51	0.94	0.94	0.00	0.31	2.20	1.57	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	11.99	5.64	2.82	0.00	0.71	0.00	0.00	2.12	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	5.61	5.05	2.24	1.12	0.00	0.00	0.56	2.24	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	16.72	9.55	1.59	0.00	1.59	0.00	0.00	5.57	2.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	15.29	5.44	3.06	0.00	0.34	0.34	0.00	5.10	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	6.50	4.87	2.60	0.97	0.32	0.00	0.00	3.90	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	5.68	2.48	1.06	1.06	0.71	0.00	0.00	1.42	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	80.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	31.59	31.59	7.90	15.79	7.90	0.00	0.00	15.79	15.79	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	2.44	1.95	0.98	1.95	0.00	0.98	0.00	1.46	1.46	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	2.48	3.47	2.48	0.50	0.00	0.50	0.00	2.48	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	2.81	0.94	0.94	1.88	0.00	0.00	0.00	1.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	3.64	1.99	1.66	0.66	0.33	0.00	0.00	3.31	0.66	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	5.26	2.78	1.55	0.62	0.00	0.00	0.00	1.24	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	3.67	3.97	0.92	0.92	0.61	0.61	0.00	3.06	0.00	0.31
Adipocyte - breast, donor1	11376-118A8	3.48	0.79	0.63	3.01	0.16	0.63	0.48	0.00	0.32	0.00
Adipocyte - breast, donor2	11327-117E4	0.96	0.64	0.80	0.96	0.16	0.00	0.00	0.32	0.00	0.32
Adipocyte - omental, donor1	11473-119C6	5.22	1.02	1.40	1.15	0.38	0.51	0.64	0.25	0.13	0.13
Adipocyte - omental, donor2	11474-119C7	0.00	0.00	0.00	1.49	0.00	0.00	0.00	0.75	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	3.35	0.67	0.33	1.00	0.00	0.33	0.00	0.00	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	1.28	0.64	0.00	0.64	0.64	0.00	0.00	0.64	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	1.10	1.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	6.77	0.90	0.45	1.35	0.00	0.45	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	0.87	0.17	0.00	0.17	0.00	0.17	0.17	0.00	0.17	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	6.06	5.08	0.98	1.17	0.20	0.98	0.59	0.00	0.39	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	6.69	1.80	1.54	0.00	0.26	1.03	0.26	0.00	0.26	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	4.46	1.39	0.28	0.84	0.00	0.00	0.28	0.28	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	6.47	1.18	0.00	0.59	0.59	0.00	0.00	0.59	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	4.83	2.57	1.45	1.93	0.16	0.80	1.13	0.08	0.24	0.56
Adipocyte differentiation, day08, donor2	13023-139D8	5.81	1.94	1.29	0.00	0.00	0.00	0.65	0.65	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	8.00	2.13	1.07	0.00	0.53	0.53	0.00	0.00	1.07	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	2.23	0.56	0.00	0.56	0.00	0.00	0.00	0.56	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	0.83	0.00	0.42	1.66	0.00	0.42	2.50	0.83	0.42	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	3.27	2.01	1.26	1.26	0.25	0.25	0.50	0.50	0.00	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	3.60	2.29	0.33	0.65	0.33	0.00	0.65	0.00	0.00	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	2.74	1.52	0.00	0.91	0.00	0.00	1.52	0.00	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	1.33	0.88	0.00	0.88	0.22	0.22	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	0.36	0.00	0.00	0.36	0.00	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	1.80	1.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	6.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	0.82	1.03	0.00	0.00	0.00	0.21	0.00	0.00	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	20.02	4.46	1.03	1.83	0.34	0.00	0.11	0.11	0.46	0.00
Anulus Pulposus Cell, donor2	11463-119B5	7.10	2.20	0.24	2.20	0.00	1.22	0.49	0.24	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	8.09	2.25	0.45	0.00	0.00	0.45	0.45	0.45	0.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	7.81	3.47	0.87	0.00	0.00	0.00	0.00	0.43	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	12.84	2.14	2.14	0.00	0.00	0.00	0.00	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	7.47	3.59	0.90	0.00	0.00	0.00	0.30	0.30	0.60	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	12.65	0.00	1.26	0.00	1.26	0.00	0.00	0.00	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	5.94	1.98	0.66	0.00	0.66	0.00	0.00	0.00	1.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	4.87	2.27	0.32	0.00	0.00	0.00	0.32	0.32	0.65	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	8.25	0.97	0.00	0.49	0.49	0.49	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	10.69	4.16	0.00	0.00	0.00	0.00	0.00	0.00	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	10.92	3.39	0.38	0.38	0.00	0.00	0.00	0.75	1.13	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	10.16	1.45	0.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	8.78	3.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	11.04	3.95	0.33	0.49	0.33	0.00	0.33	0.00	0.00	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	8.19	1.36	1.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	8.29	4.22	0.90	0.30	0.15	0.00	0.15	0.15	0.30	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	12.86	3.75	1.61	0.54	0.00	0.00	0.00	0.00	1.61	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	8.50	2.65	1.13	0.00	0.00	0.00	0.00	0.76	0.57	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	10.42	4.28	1.07	0.27	0.00	0.27	0.27	0.27	0.53	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	5.85	1.95	0.00	0.00	0.00	0.00	0.00	0.98	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	6.63	1.49	1.00	0.50	0.00	0.17	0.00	0.33	0.33	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	8.41	1.20	1.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	10.62	3.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	7.72	2.74	1.20	0.00	0.00	0.00	0.00	0.17	0.00	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	6.80	3.88	0.49	0.00	0.00	0.00	0.00	0.49	0.97	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	7.59	3.42	0.76	0.76	0.00	0.00	0.00	0.76	1.14	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	8.48	1.21	1.21	1.21	0.00	0.00	0.00	1.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	6.84	3.99	1.14	0.57	0.57	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	6.41	1.28	1.07	0.21	0.21	0.00	0.00	0.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	6.19	3.10	0.77	0.26	0.52	0.00	0.00	0.00	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	7.04	1.41	0.47	0.00	0.47	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	4.50	0.96	0.96	0.00	0.32	0.00	0.32	0.64	0.96	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	1.43	4.99	0.71	0.71	0.71	0.00	0.71	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	5.85	2.34	0.00	0.00	0.00	0.00	0.00	0.58	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	10.24	2.41	0.60	0.60	0.30	0.00	0.00	0.90	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	8.32	1.19	0.00	0.00	0.00	0.00	0.00	2.38	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	6.61	5.09	0.51	0.00	0.00	0.00	0.00	0.51	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	11.97	4.33	2.04	0.25	0.25	0.00	0.00	0.25	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	6.35	3.18	1.27	0.00	0.00	0.00	0.00	0.00	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	4.75	1.29	0.86	0.43	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	6.35	2.54	0.64	0.00	0.00	0.21	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	4.64	1.16	0.87	0.29	0.00	0.29	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	2.83	0.94	0.94	0.00	0.00	0.00	0.00	0.00	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	7.46	2.20	1.02	0.17	0.34	0.17	0.00	0.00	0.00	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	6.95	2.32	0.00	0.00	2.32	0.00	0.00	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	8.45	2.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	10.72	2.57	1.29	0.43	0.00	0.43	0.00	0.21	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	9.63	1.80	1.20	0.00	1.20	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	8.75	1.46	0.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	7.13	2.30	0.92	0.46	0.69	0.00	0.00	0.00	0.46	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	7.65	0.00	0.00	0.00	2.55	0.00	0.00	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	7.88	2.80	1.27	0.25	0.00	0.00	0.25	0.00	0.25	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	9.08	1.24	1.03	0.00	0.41	0.21	0.00	0.21	0.21	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	6.12	1.22	1.53	0.00	0.31	0.00	0.00	0.00	0.61	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	6.69	2.39	1.91	0.00	0.00	0.00	0.00	0.48	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	7.10	2.22	2.00	0.00	0.44	0.00	0.00	0.44	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	10.68	1.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	4.98	1.11	0.00	0.00	0.00	0.00	0.00	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	6.62	3.71	0.53	0.26	0.00	0.26	0.00	0.79	0.79	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	4.72	2.91	1.45	0.36	0.36	0.00	0.00	0.36	0.73	0.00
Astrocyte - cerebellum, donor1	11500-119F6	6.14	1.60	0.12	1.72	0.37	0.25	0.12	0.12	0.00	0.00
Astrocyte - cerebellum, donor2	11580-120F5	2.05	0.17	0.17	0.86	0.00	0.68	0.00	0.00	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	2.31	0.84	0.63	1.05	0.21	0.21	0.00	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	12.90	6.62	1.74	2.44	0.70	0.00	0.35	0.00	0.35	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	10.19	4.37	1.78	1.62	0.32	0.65	0.00	1.46	0.81	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	7.76	2.09	0.60	2.39	0.30	0.89	0.00	0.15	0.45	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	42.32	14.57	0.80	0.80	0.57	0.92	0.00	0.92	1.72	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	34.83	13.03	0.25	1.63	0.50	0.75	0.25	0.25	0.25	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	39.83	15.02	1.02	1.25	0.57	1.02	0.34	0.34	1.02	0.11
Basophils, donor1	12241-129G9	156.14	70.35	11.51	2.35	5.75	0.26	1.31	0.52	0.00	0.78
Basophils, donor2	12242-129H1	402.29	178.23	57.73	1.08	25.26	0.36	2.89	0.36	1.80	2.16
Basophils, donor3	12243-129H2	184.78	74.38	15.58	2.35	5.59	0.15	3.09	0.15	0.44	1.47
Bronchial Epithelial Cell, donor1	11511-119G8	0.86	0.00	0.00	0.65	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	0.00	0.00	0.00	1.37	0.00	0.46	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	2.51	1.88	0.00	0.00	0.00	0.63	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	1.25	0.62	0.21	1.04	0.00	0.21	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	6.91	0.69	0.46	0.46	0.00	0.69	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	5.58	2.34	0.54	1.26	0.00	0.36	0.00	0.72	0.18	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	68.33	20.30	2.68	0.21	1.85	0.10	0.41	0.62	0.31	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	41.46	14.91	5.59	0.70	1.86	0.23	0.23	0.47	0.23	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	57.88	23.98	2.56	0.32	1.60	0.00	0.00	0.32	0.32	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	144.79	51.71	10.34	0.00	10.34	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	233.88	85.10	27.61	2.82	11.27	1.13	2.25	1.13	0.56	3.38
CD14+ Monocytes, donor2	11305-117B9	256.50	77.40	35.82	2.78	10.21	0.19	1.67	2.78	4.08	1.11
CD14+ Monocytes, donor3	11381-118B4	206.14	68.28	23.71	3.29	5.27	0.22	2.41	3.29	2.41	1.98
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	67.08	31.13	3.96	0.28	2.83	0.57	3.96	0.28	0.57	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	48.52	28.43	5.31	1.90	2.65	0.38	1.52	0.76	0.76	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	85.14	26.63	3.62	0.66	6.25	0.66	2.63	0.33	0.00	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	115.06	39.75	11.13	3.47	3.61	0.72	0.58	2.60	2.89	0.58
CD14+ monocytes - mock treated, donor2	11873-125C1	111.04	42.85	13.88	3.02	5.43	0.30	1.81	0.60	1.51	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	120.58	32.22	15.40	3.08	6.16	1.18	0.24	2.37	0.95	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	130.24	38.17	14.06	2.85	2.68	0.17	1.00	1.84	1.84	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	119.51	47.20	12.70	1.66	2.76	0.55	0.83	3.31	0.55	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	211.98	80.58	21.32	1.98	3.97	0.74	0.99	2.48	2.23	1.24
CD14+ monocytes - treated with BCG, donor1	11860-125A6	133.34	41.31	11.55	1.17	2.55	0.59	0.39	3.52	3.13	0.59
CD14+ monocytes - treated with BCG, donor2	11870-125B7	150.99	53.59	15.85	1.60	2.14	0.71	0.89	2.14	2.67	0.71
CD14+ monocytes - treated with BCG, donor3	11880-125C8	303.59	98.15	31.77	3.26	4.79	1.09	0.87	1.52	1.96	1.52
CD14+ monocytes - treated with Candida, donor1	11868-125B5	259.41	83.35	22.48	4.92	5.15	0.00	1.64	4.45	1.87	1.17
CD14+ monocytes - treated with Candida, donor2	11878-125C6	359.59	116.17	29.57	2.11	5.28	0.53	4.22	4.22	4.22	2.64
CD14+ monocytes - treated with Candida, donor3	11888-125D7	340.57	107.61	21.08	1.11	3.33	0.00	4.44	0.00	2.22	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	134.02	37.93	16.36	2.08	4.31	0.89	0.45	5.06	2.38	0.45
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	134.10	40.31	21.15	1.00	4.19	1.40	0.80	2.59	1.80	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	197.58	69.54	18.53	1.46	5.62	0.83	1.04	0.42	1.25	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	277.29	80.07	41.64	2.06	2.97	0.69	1.60	4.12	5.72	1.60
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	308.77	102.47	34.38	1.81	7.46	0.68	3.62	0.90	0.68	0.90
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	268.86	78.13	27.06	0.87	3.93	1.31	3.06	2.62	3.06	1.31
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	78.28	22.06	6.19	2.96	2.15	0.00	0.54	2.15	1.61	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	133.64	39.08	14.13	2.79	2.62	0.35	0.70	3.84	2.62	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	132.56	32.40	15.57	2.10	3.79	1.26	1.26	3.79	1.68	1.68
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	112.98	41.70	29.39	2.57	4.59	0.37	0.92	4.41	3.49	0.92
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	81.73	29.59	17.26	1.76	2.11	0.35	1.06	0.70	1.76	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	99.59	43.87	20.62	1.75	3.51	0.88	0.44	1.32	3.51	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	159.38	70.27	26.16	1.22	3.49	0.17	1.05	6.10	4.71	1.05
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	186.58	82.14	27.13	1.86	4.46	1.12	1.86	5.58	7.43	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	429.59	148.08	43.97	2.59	4.53	0.00	2.59	1.08	4.10	1.08
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	92.13	36.44	16.38	2.05	1.64	0.00	1.64	2.05	2.05	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	180.34	69.08	29.44	1.85	4.87	1.16	0.70	0.46	0.93	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	196.73	79.11	31.78	2.55	5.10	0.93	1.39	1.39	1.86	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	133.39	36.18	6.10	0.65	3.92	0.00	2.40	0.65	0.65	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	108.80	35.57	8.08	0.92	3.23	1.39	0.46	1.15	0.69	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	135.17	42.67	7.58	0.87	2.60	0.65	0.87	0.00	0.87	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	202.44	68.67	9.81	2.02	7.32	0.47	2.34	1.09	1.09	0.93
CD14+CD16- Monocytes, donor2	11799-124C8	196.30	70.38	13.80	1.92	5.76	0.52	1.92	0.87	0.87	1.57
CD14+CD16- Monocytes, donor3	11910-125G2	346.05	130.44	18.51	3.12	13.38	0.67	4.91	0.45	1.56	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	142.90	36.75	8.68	2.04	4.59	1.28	1.53	1.02	0.51	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	110.00	37.55	8.78	1.98	4.83	1.32	1.10	0.66	1.32	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	169.07	53.48	9.90	1.47	3.58	1.47	1.68	0.21	0.42	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	107.71	71.13	6.10	0.00	8.13	0.00	0.00	0.00	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	124.07	71.19	4.75	1.36	2.03	0.68	1.36	0.00	0.68	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	119.09	68.35	8.28	1.04	9.32	0.00	0.00	1.04	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	179.10	131.66	4.80	1.60	5.33	2.13	1.07	0.53	2.13	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	144.74	80.95	10.19	1.61	6.97	1.61	0.00	1.61	1.61	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	138.28	68.09	6.32	0.70	2.81	0.00	1.40	0.70	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	111.38	66.67	6.27	0.78	6.27	0.00	0.78	0.78	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	137.10	79.10	5.27	0.00	3.95	2.64	1.32	0.00	2.64	0.00
CD19+ B Cells, donor1	11544-120B5	503.00	305.75	20.55	4.11	5.75	3.29	3.29	9.86	2.47	4.93
CD19+ B Cells, donor2	11624-122B4	370.69	189.34	14.51	2.18	6.53	2.90	4.35	2.90	2.90	2.18
CD19+ B Cells, donor3	11705-123B4	435.16	229.70	25.24	3.03	5.05	1.51	0.50	2.02	2.02	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	139.80	46.47	33.54	6.46	10.51	2.42	4.04	0.00	0.40	2.42
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	82.30	27.56	24.37	4.79	3.20	0.00	1.20	0.00	0.40	2.80
CD34+ Progenitors, donor1	11545-120B6	107.43	50.20	4.02	0.00	2.01	0.00	2.01	3.01	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	229.78	114.61	25.84	1.69	6.74	1.12	0.56	1.69	0.56	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	44.34	12.78	0.38	1.13	1.50	0.00	0.00	0.38	0.75	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	61.33	22.77	1.35	0.00	2.03	0.45	0.45	0.23	0.00	0.68
CD4+ T Cells, donor1	11225-116C1	450.25	262.44	45.35	3.93	27.85	1.07	1.43	1.79	1.79	1.79
CD4+ T Cells, donor2	11306-117C1	330.06	129.82	45.31	3.67	14.08	0.61	4.90	11.63	8.57	2.45
CD4+ T Cells, donor3	11382-118B5	430.04	202.52	48.80	3.96	15.86	0.30	3.05	5.18	5.79	3.05
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	40.84	30.88	1.79	0.26	1.28	0.00	0.77	0.26	0.77	1.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	32.79	34.36	2.25	0.67	0.67	0.22	0.45	0.22	0.45	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	27.88	38.52	1.15	0.86	1.15	0.29	0.29	0.29	0.29	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	218.08	132.27	15.65	2.84	9.48	0.47	0.95	1.90	0.00	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	146.79	138.36	9.83	2.11	7.02	2.11	0.00	0.70	1.40	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	184.59	85.70	6.59	3.30	3.30	3.30	0.00	0.00	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	46.10	31.65	5.93	0.14	2.02	0.43	0.87	0.43	0.14	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	26.27	18.30	2.37	0.34	1.02	0.17	0.17	0.85	0.85	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	27.57	24.34	3.06	0.64	0.81	0.16	0.48	0.64	0.81	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	134.49	80.25	13.90	0.45	1.79	0.00	0.45	0.45	0.45	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	111.11	60.09	6.29	0.00	4.19	0.70	1.40	0.70	1.40	1.05
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	176.87	118.79	12.32	1.76	7.92	0.00	0.88	0.00	0.88	1.76
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	47.65	36.26	6.32	1.26	3.37	0.00	0.84	0.84	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	18.08	13.30	1.66	0.83	1.04	0.21	0.00	1.45	1.45	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	18.38	20.05	1.00	2.34	0.33	0.67	0.00	0.67	1.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	323.60	209.93	23.11	5.44	14.41	1.90	1.09	1.63	0.82	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	331.75	213.31	16.61	2.14	9.11	1.07	2.14	1.61	2.14	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	220.57	134.49	3.59	7.17	1.79	0.00	1.79	1.79	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	46.17	28.74	3.34	0.37	1.67	0.19	1.11	0.19	0.00	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	23.18	19.93	1.95	0.22	1.73	0.00	0.65	0.00	0.22	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	33.62	17.44	4.83	0.21	1.68	0.00	0.42	0.42	0.42	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	265.44	136.51	17.70	1.01	12.13	0.51	0.51	0.00	0.51	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	233.52	156.84	15.16	1.30	8.67	0.43	1.30	0.87	0.87	1.30
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	380.47	207.45	30.51	0.00	14.38	0.00	1.74	1.31	0.87	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	58.39	33.16	3.96	0.99	0.99	1.98	1.98	0.00	0.49	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	31.39	35.08	2.77	0.92	2.77	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	40.48	36.29	0.00	1.40	1.40	0.00	1.40	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	85.29	61.20	3.88	0.83	6.65	0.55	2.49	0.55	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	86.62	66.01	4.17	0.98	5.89	0.98	1.72	0.25	0.25	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	81.62	64.68	1.54	0.00	7.70	1.54	1.54	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	80.58	56.58	2.15	0.72	4.66	0.36	1.07	0.36	0.72	1.07
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	48.47	38.78	5.54	1.38	1.38	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	319.54	199.38	66.13	4.58	31.10	1.96	3.27	2.29	2.62	3.27
CD8+ T Cells, donor2	11307-117C2	215.87	96.11	62.70	4.13	17.65	0.75	1.50	7.13	5.26	1.50
CD8+ T Cells, donor3	11383-118B6	256.28	135.08	47.47	3.03	14.90	2.02	1.01	5.55	4.80	2.27
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	1.15	0.00	0.00	0.00	0.00	0.00	0.00	0.23	0.46	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	0.48	0.00	0.24	0.24	0.48	0.00	0.00	0.48	0.24	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	3.28	0.27	0.82	0.27	0.00	0.00	0.00	0.00	0.27	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	1.80	0.30	0.30	0.00	0.00	0.30	0.00	0.60	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	1.20	0.00	0.24	0.00	0.00	0.24	0.00	0.24	0.24	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	1.36	0.23	0.00	0.00	0.23	0.00	0.23	0.23	0.23	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	1.52	0.22	0.22	0.43	0.22	0.22	0.00	0.43	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	1.58	0.53	0.26	0.00	0.00	0.26	0.00	0.26	0.26	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	0.94	0.00	0.47	0.47	0.23	0.23	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	2.42	0.60	0.30	0.00	0.00	0.00	0.00	0.00	0.60	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	2.03	0.58	0.00	0.00	0.00	0.00	0.00	0.29	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	1.87	0.27	0.00	0.27	0.27	0.00	0.00	0.27	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	8.76	3.50	0.44	0.00	0.00	0.44	0.44	0.44	0.00	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	9.11	2.28	1.82	1.37	0.00	0.00	0.46	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	9.70	1.49	2.24	0.00	0.75	0.00	0.00	0.75	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	0.72	0.00	0.00	0.36	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	2.59	0.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	2.12	0.24	0.71	0.24	0.00	0.00	0.00	0.24	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	0.32	0.00	0.32	0.32	0.00	0.63	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	0.31	0.92	0.00	0.92	0.00	0.00	0.00	0.31	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	0.32	0.32	0.96	0.32	0.00	0.32	0.00	0.00	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	3.44	1.91	1.53	1.15	0.38	0.38	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	3.15	1.58	0.79	0.39	0.39	0.79	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	5.29	2.27	0.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	17.67	2.41	0.80	0.00	0.00	0.00	0.00	0.00	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	17.49	7.69	2.80	1.40	1.40	0.00	0.00	1.40	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	13.02	3.01	4.01	3.01	0.00	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	1.83	0.00	1.83	12.79	0.00	0.00	0.00	5.48	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	8.40	3.46	0.99	1.48	0.00	0.00	0.00	0.00	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	4.31	1.05	0.53	0.63	0.21	0.32	0.11	0.11	0.00	0.00
Chondrocyte - de diff, donor1	11261-116G1	1.04	0.35	0.69	1.04	0.35	0.69	0.35	0.35	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	1.42	1.07	0.36	0.00	0.00	0.36	0.00	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	1.48	0.11	0.00	0.57	0.00	0.11	0.00	0.11	0.23	0.00
Chondrocyte - re diff, donor2	11339-117F7	11.64	1.79	1.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	8.49	2.02	4.85	1.62	0.40	0.00	0.00	0.00	0.81	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	33.97	17.44	3.56	3.44	1.84	1.15	0.00	0.23	0.57	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	18.38	5.99	1.28	3.42	0.21	1.07	0.00	1.07	1.07	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	15.84	6.19	1.15	3.45	0.27	0.88	0.00	0.53	0.62	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	14.12	6.14	2.02	6.24	0.73	2.66	0.92	0.37	0.28	1.01
Corneal Epithelial Cells, donor1	11526-119I5	0.44	1.76	0.00	0.88	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	1.14	1.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	1.28	0.77	0.00	0.51	0.26	0.51	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	7.92	4.29	0.17	0.33	0.17	0.50	0.17	0.17	0.33	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	9.15	3.47	0.32	1.26	0.32	0.63	0.63	0.32	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	3.45	0.00	0.00	0.00	0.00	0.00	0.00	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	6.16	2.81	0.11	0.11	0.11	0.22	0.00	0.32	0.11	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	200.20	60.47	16.74	0.34	7.52	0.00	0.34	1.02	2.05	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	167.13	54.84	11.75	1.31	4.57	0.00	0.00	0.00	0.00	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	206.64	63.88	17.91	0.48	6.29	0.00	0.48	0.48	0.00	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	11.67	2.50	0.67	0.67	0.17	0.00	0.17	0.17	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	4.69	0.59	0.59	0.00	0.00	0.59	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	7.64	1.98	0.28	0.57	0.28	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	5.50	0.79	0.39	1.18	0.00	0.39	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	6.69	1.45	0.00	0.29	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	14.35	4.24	0.94	0.94	0.00	0.24	0.00	0.47	0.47	0.00
Endothelial Cells - Artery, donor3	11413-118E9	9.82	1.75	0.35	1.05	0.00	0.70	0.00	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	27.04	7.76	0.66	1.55	0.22	0.66	0.00	0.44	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	37.42	8.82	2.43	4.56	0.00	0.91	0.30	0.61	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	47.92	15.79	1.13	3.66	0.56	1.69	0.00	0.28	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	5.05	0.89	0.59	0.30	0.00	0.59	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	10.93	4.17	0.00	2.08	0.00	0.52	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	5.81	0.85	0.14	0.99	0.14	0.71	0.00	0.00	0.43	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	17.21	4.40	0.80	1.20	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	5.77	0.52	0.52	0.52	0.00	0.00	0.00	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	54.67	11.93	2.24	6.71	0.37	2.48	0.00	0.12	0.75	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	14.99	4.13	0.43	4.56	0.43	1.52	0.00	0.43	0.22	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	21.25	5.62	0.49	3.79	0.24	1.34	0.00	0.24	0.24	0.00
Endothelial Cells - Vein, donor1	11267-116G7	11.38	7.96	0.00	2.28	1.14	0.00	0.00	0.00	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	9.78	3.49	0.00	0.00	0.00	1.40	0.00	0.00	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	9.73	1.73	0.47	1.73	0.00	0.31	0.00	0.00	0.00	0.00
Eosinophils, donor1	12244-129H3	182.96	106.73	30.49	15.25	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	939.00	287.15	19.80	9.90	18.15	4.95	0.00	8.25	1.65	1.65
Eosinophils, donor3	12246-129H5	1091.45	363.82	46.37	10.70	7.13	0.00	0.00	10.70	0.00	7.13
Esophageal Epithelial Cells, donor1	11507-119G4	0.24	0.00	0.00	1.47	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	0.00	0.00	0.00	0.00	0.00	2.08	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	3.28	2.05	0.82	1.64	0.82	0.82	0.00	0.41	0.00	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	2.96	0.44	0.00	0.00	0.22	0.00	0.11	0.33	0.11	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	3.58	0.87	0.33	0.00	0.00	0.00	0.00	1.19	0.22	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	9.10	2.43	1.21	1.09	0.49	0.24	0.24	0.24	0.24	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	47.63	11.33	7.37	2.87	0.96	1.23	0.96	0.14	0.14	1.36
Fibroblast - Aortic Adventitial, donor2	11326-117E3	4.54	0.95	0.21	0.32	0.11	0.21	0.00	0.32	0.32	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	31.09	8.96	3.69	1.32	1.58	1.84	0.53	0.26	0.00	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	9.63	1.33	1.00	1.00	0.00	0.33	0.66	0.00	0.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	1.36	2.27	0.45	1.36	0.00	0.00	0.00	0.91	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	2.27	3.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	2.52	0.79	0.16	0.47	0.16	0.32	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor4	11452-119A3	32.74	9.70	2.73	5.76	2.42	0.61	1.52	0.61	0.00	0.30
Fibroblast - Cardiac, donor5	11456-119A7	13.96	2.79	0.89	3.05	0.25	1.40	0.00	0.25	0.13	0.00
Fibroblast - Cardiac, donor6	11460-119B2	13.04	3.03	0.76	3.34	0.30	1.52	0.15	0.00	0.15	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	8.58	2.28	0.40	1.88	0.27	0.54	0.27	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	15.53	4.75	0.86	2.16	0.00	0.00	0.00	1.29	0.43	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	5.86	1.46	0.00	2.93	2.93	1.46	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	6.69	2.54	0.69	1.61	0.00	0.00	0.23	0.00	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	16.62	4.24	1.02	1.53	1.02	0.85	0.51	0.00	0.17	0.17
Fibroblast - Dermal, donor1	11269-116G9	10.80	4.46	0.23	0.94	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	7.55	2.36	0.94	0.00	0.47	0.00	0.00	0.00	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	8.82	1.45	0.97	0.97	0.00	0.36	0.00	0.60	0.00	0.00
Fibroblast - Dermal, donor4	11450-119A1	14.92	4.63	3.17	2.83	0.34	0.90	0.00	0.45	0.00	0.00
Fibroblast - Dermal, donor5	11454-119A5	13.78	4.54	2.27	2.44	0.70	0.17	0.00	0.52	0.35	0.00
Fibroblast - Dermal, donor6	11458-119A9	11.53	3.09	2.27	2.92	0.16	1.46	0.00	0.16	0.00	0.00
Fibroblast - Gingival, donor1	11237-116D4	11.04	2.92	1.46	0.62	0.21	0.42	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	6.81	1.83	1.05	1.83	0.00	0.00	0.26	0.00	0.00	0.00
Fibroblast - Gingival, donor2	11318-117D4	10.15	2.37	0.13	1.32	0.00	0.40	0.00	0.26	0.13	0.00
Fibroblast - Gingival, donor3	11394-118C8	9.48	3.09	0.87	0.58	0.19	0.29	0.00	0.10	0.00	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	4.16	3.12	1.04	2.08	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	1.94	0.53	0.53	0.88	0.00	0.35	0.00	0.18	0.18	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	6.70	1.56	0.78	1.71	0.16	0.62	0.31	0.47	0.16	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	8.25	1.76	1.08	0.95	0.14	0.14	0.00	0.41	0.14	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	2.82	1.76	1.06	1.41	0.00	1.06	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	8.19	2.19	0.88	1.90	0.15	0.15	0.15	0.29	0.00	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	8.59	2.45	1.23	1.36	0.41	0.14	0.14	0.55	0.14	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	8.89	1.86	2.08	1.97	0.55	0.77	0.11	0.11	0.33	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	4.11	1.61	0.59	2.20	0.15	0.44	0.29	0.15	0.00	0.15
Fibroblast - Lung, donor1	11270-116H1	1.36	0.00	0.00	2.72	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	25.37	2.98	2.98	0.00	0.00	0.00	0.00	4.48	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	5.28	0.00	0.00	0.84	0.00	0.42	0.00	0.00	0.42	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	3.33	0.00	0.00	0.83	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	2.80	2.80	0.00	1.40	0.00	1.40	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	0.28	0.00	0.28	0.28	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	4.06	1.62	0.00	1.22	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	3.99	3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	0.00	0.00	5.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	12.03	4.27	0.39	1.55	0.19	0.97	0.00	0.39	0.19	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	15.77	4.25	1.06	2.43	0.30	0.91	0.00	0.15	0.61	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	24.17	8.26	1.84	2.45	0.31	0.61	0.00	0.31	0.00	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	4.58	1.14	0.00	1.14	0.38	0.38	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	1.89	0.27	0.27	1.35	0.27	0.54	0.00	0.27	0.54	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	1.74	0.58	0.35	0.46	0.12	0.12	0.00	0.12	0.35	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	4.97	2.76	1.11	0.88	0.00	0.22	0.00	0.11	0.00	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	2.84	1.63	0.20	0.61	0.00	0.41	0.00	0.00	0.00	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	1.34	0.00	0.67	0.67	0.00	0.67	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	10.67	1.19	0.00	0.40	0.40	0.40	0.40	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	22.82	8.93	6.75	7.74	0.40	1.59	0.00	0.79	0.40	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	10.12	4.62	1.95	2.31	0.18	0.00	0.18	0.18	0.18	0.71
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	7.69	2.56	1.77	1.18	0.39	0.59	0.00	0.00	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	14.44	8.42	3.61	3.01	1.20	1.50	0.60	0.90	0.60	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	12.52	3.45	2.37	0.76	0.54	0.32	0.32	0.11	0.00	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	13.16	5.31	2.02	3.04	0.51	2.53	0.00	1.27	0.51	0.00
Fibroblast - skin normal, donor1	11553-120C5	4.10	1.97	0.16	0.98	0.49	0.00	0.16	0.16	0.00	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	12.63	4.41	5.01	5.01	1.00	2.41	0.20	0.00	0.40	0.00
Fibroblast - skin normal, donor2	11561-120D4	2.21	0.40	0.80	1.51	0.10	0.80	0.00	0.40	0.10	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	21.76	9.67	3.93	7.56	0.30	3.32	0.00	0.91	0.30	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	9.94	5.22	1.99	1.33	0.58	0.33	0.66	0.58	0.33	0.25
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	12.65	4.27	0.68	1.37	1.20	0.34	2.22	0.34	0.17	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	22.66	9.20	3.61	0.66	1.31	1.31	1.97	0.66	0.00	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	5.33	2.45	2.02	1.38	0.43	0.64	0.00	0.11	0.00	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	2.70	1.18	0.34	1.86	0.00	0.17	0.17	0.17	0.00	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	2.51	0.31	0.16	0.31	0.16	0.31	0.00	0.31	0.47	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	9.59	3.49	2.61	0.87	0.00	0.00	0.87	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	13.52	4.68	2.95	0.69	0.52	0.17	0.00	0.17	0.00	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	13.01	6.25	3.64	2.08	0.00	0.00	0.26	1.04	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	10.22	4.09	1.53	0.51	0.26	0.51	0.00	0.00	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	21.44	9.95	9.19	3.06	1.53	0.00	1.53	0.77	1.53	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	30.63	14.68	18.50	5.10	2.55	0.00	1.91	0.64	4.47	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	81.59	40.51	37.94	7.13	7.13	1.43	0.57	4.28	4.56	1.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	3.58	2.21	9.93	5.24	1.65	0.55	0.00	2.21	0.55	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	18.27	11.19	7.76	5.94	0.91	1.37	0.46	1.60	1.60	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	48.54	22.98	17.44	7.13	4.36	0.59	0.20	4.36	1.78	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	4.49	4.23	11.37	4.76	2.64	1.32	0.00	2.11	0.79	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	5.87	3.59	5.54	7.18	3.91	1.30	0.00	0.65	0.65	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	88.44	44.66	23.00	10.61	4.86	1.33	0.88	4.42	3.54	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	40.56	23.04	15.69	2.12	3.53	0.57	0.57	0.99	0.99	0.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	31.65	13.67	6.90	2.96	2.46	0.37	0.25	1.60	1.35	0.86
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	34.65	16.39	10.48	1.88	2.69	0.27	0.81	1.88	1.34	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	40.14	14.50	5.20	3.35	0.87	0.87	0.37	1.61	0.74	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	49.28	24.50	6.09	4.15	1.80	0.83	0.42	1.38	1.11	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	68.92	25.82	10.98	2.64	1.83	0.81	0.00	1.02	1.22	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	31.26	11.87	3.42	2.51	2.28	0.91	0.46	1.83	0.46	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	36.37	11.96	3.61	3.86	0.87	0.75	0.62	0.75	0.87	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	54.86	19.23	4.59	5.46	0.66	0.44	0.66	1.31	2.40	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	25.71	9.46	5.61	1.77	2.36	0.89	0.30	0.59	1.18	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	25.43	8.90	4.13	3.02	0.79	0.79	0.16	1.11	0.95	0.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	41.11	14.97	4.69	3.80	1.34	0.89	0.45	0.45	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	15.32	4.44	3.63	2.22	1.01	0.20	0.20	1.61	1.01	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	19.85	6.96	4.07	3.73	0.68	0.17	0.34	1.02	0.68	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	55.33	17.47	8.87	4.61	2.31	0.71	0.44	0.35	0.44	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	31.01	12.38	5.62	2.39	4.37	0.94	1.14	1.04	0.62	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	30.91	11.27	5.98	3.42	2.22	0.68	0.68	0.17	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	15.16	6.09	2.77	2.43	0.55	0.77	0.33	0.89	0.33	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	30.03	10.65	6.07	3.16	2.00	0.50	0.25	0.25	0.08	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	34.71	13.07	4.70	3.06	3.68	1.23	0.41	0.41	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	17.74	6.81	2.27	2.48	0.83	1.44	0.41	0.00	0.41	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	14.41	6.11	2.65	1.84	1.15	0.58	0.35	0.69	0.46	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	17.68	7.50	3.34	1.50	1.00	1.33	0.50	0.50	0.67	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	12.78	3.53	1.98	1.32	1.10	0.44	0.22	0.44	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	18.57	6.40	3.94	1.48	0.98	0.25	0.25	1.11	0.61	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	13.62	5.19	3.40	3.24	1.13	0.81	0.00	0.97	0.81	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	20.21	8.66	2.89	3.53	1.60	0.96	0.32	0.96	0.64	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	12.13	4.26	0.76	1.33	0.66	0.47	0.19	0.19	0.28	0.76
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	17.72	4.11	2.21	2.06	1.27	0.32	0.47	0.63	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	22.20	8.21	7.91	2.13	1.22	0.61	1.22	0.30	1.82	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	18.09	5.65	3.03	1.99	0.94	0.21	0.42	0.52	0.52	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	14.05	3.07	1.98	0.88	0.66	0.44	0.44	0.44	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	15.99	6.45	1.68	1.96	0.28	0.00	0.00	0.28	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	11.11	3.43	1.48	0.74	0.46	0.09	0.00	0.09	0.46	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	13.37	4.28	1.60	0.53	1.07	0.00	0.00	0.27	0.27	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	19.28	3.83	1.99	1.53	0.77	0.31	0.00	1.07	0.31	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	9.59	2.33	1.17	1.30	0.39	0.26	0.00	0.52	0.26	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	6.23	2.71	1.08	1.08	0.81	0.81	0.00	0.54	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	18.99	4.24	2.58	1.29	0.74	0.18	0.37	0.37	0.55	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	16.67	3.95	3.29	1.54	1.97	0.22	0.44	0.22	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	12.89	1.98	5.95	2.98	0.99	0.99	1.98	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	10.95	3.17	0.79	1.19	0.13	0.40	0.26	0.66	0.13	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	10.89	2.22	1.21	0.40	0.00	0.00	0.20	0.40	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	24.65	9.40	5.85	3.56	5.34	0.25	0.76	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	102.72	57.53	30.06	5.18	7.17	1.19	1.39	0.80	0.40	1.79
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	50.54	34.36	16.02	4.47	3.24	0.77	0.62	2.62	1.39	0.62
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	42.14	32.12	24.35	4.50	6.34	0.82	0.20	0.82	1.23	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	23.16	11.58	10.95	2.82	2.50	0.00	0.00	0.31	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	19.78	6.22	8.19	1.70	2.26	0.28	0.28	0.00	0.28	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	46.12	20.75	14.76	2.77	3.23	2.31	0.46	5.07	2.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	44.55	22.27	9.90	0.00	0.00	2.47	0.00	2.47	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	40.61	10.06	16.25	10.06	4.25	1.55	0.77	2.32	1.55	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	46.53	12.84	22.46	3.21	8.02	1.60	0.00	8.02	4.81	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	15.65	12.17	5.22	3.48	6.96	0.00	0.00	5.22	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	17.58	7.16	11.07	4.88	5.21	0.98	0.00	0.65	2.60	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	32.94	7.00	14.00	5.35	3.29	2.06	0.00	4.12	5.77	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	16.66	3.33	16.66	3.33	0.00	0.00	0.00	6.66	6.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	18.46	5.59	8.39	9.51	2.80	1.40	0.28	2.24	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	13.07	7.84	10.46	4.58	1.63	0.33	0.33	1.63	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	11.74	3.36	7.55	6.71	4.19	2.52	0.00	0.00	2.52	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	12.09	7.00	7.32	4.13	2.86	0.64	0.64	0.95	1.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	8.83	6.79	5.77	5.43	2.72	0.00	0.00	1.70	0.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	18.79	2.09	6.26	6.26	4.18	0.00	0.00	0.00	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	10.31	4.58	5.73	5.15	1.15	1.15	0.00	1.72	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	5.62	3.85	4.14	1.48	1.18	0.59	0.30	0.89	0.89	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	22.02	6.78	11.86	1.69	6.78	0.00	0.00	3.39	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	15.33	5.80	6.21	4.97	5.38	0.83	0.83	0.83	2.07	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	13.35	2.99	7.59	3.68	4.37	0.69	0.46	1.15	0.69	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	5.27	10.54	10.54	15.81	5.27	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	15.38	1.54	6.54	5.77	2.31	0.77	0.00	1.92	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	15.32	5.22	4.56	4.24	2.93	0.33	0.00	1.30	0.65	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	10.03	2.68	4.01	4.01	1.34	2.68	0.00	1.34	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	16.57	8.09	6.93	5.39	3.47	2.70	0.39	0.00	1.16	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	8.22	2.74	5.82	7.87	2.40	0.68	0.00	2.40	1.03	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	12.42	7.45	9.94	7.45	0.00	2.48	0.00	2.48	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	16.51	6.61	5.19	3.77	2.83	1.89	0.47	1.89	0.47	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	10.26	5.43	6.03	4.22	1.81	0.00	0.00	1.81	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	25.43	6.10	3.05	4.58	2.54	1.02	0.00	0.51	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	15.95	7.58	7.58	3.99	3.19	0.40	0.80	0.40	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	20.23	7.40	8.39	6.41	5.92	0.49	1.48	1.48	0.00	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	24.79	7.08	10.62	4.72	2.36	0.00	2.36	3.54	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	14.00	3.50	2.33	6.42	4.67	0.58	0.00	0.58	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	22.38	8.34	6.58	4.39	3.95	2.19	0.44	1.76	0.88	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	26.28	9.32	14.41	5.93	5.09	3.39	0.85	3.39	5.93	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	10.15	3.58	4.78	2.39	1.19	1.79	0.00	4.78	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	16.50	8.73	9.22	2.91	3.88	0.00	0.00	1.46	1.46	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	4.57	0.00	0.00	1.14	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	2.08	0.83	0.83	1.66	0.00	0.83	0.42	0.42	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	3.37	1.12	0.00	2.25	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	6.98	3.49	1.90	0.63	0.63	0.00	0.00	0.63	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	1.67	0.42	0.00	0.42	0.00	0.42	0.84	0.42	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	1.97	0.93	0.35	0.58	0.00	0.00	0.00	0.12	0.58	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	2.19	0.84	0.17	0.34	0.00	0.68	0.00	0.51	0.00	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	2.50	0.91	0.23	0.91	0.00	0.23	0.00	0.00	0.23	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	3.06	1.09	0.33	0.77	0.11	0.11	0.00	0.44	0.44	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	3.44	0.64	0.43	0.00	0.00	0.00	0.21	0.21	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	1.72	0.65	0.22	0.22	0.00	0.22	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	2.12	0.37	0.50	0.62	0.00	0.37	0.00	0.00	0.12	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	2.40	0.69	0.34	0.51	0.00	0.00	0.00	0.17	0.17	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	2.24	0.96	0.00	1.28	0.00	0.00	0.32	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	4.48	0.00	0.56	0.56	0.00	1.68	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	2.60	0.43	0.00	0.00	0.00	0.43	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	29.08	7.93	0.00	0.00	5.29	0.00	2.64	2.64	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	1.76	0.35	0.00	0.35	0.00	0.00	0.35	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	1.45	1.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	4.90	1.75	0.52	0.35	0.00	0.35	0.00	0.00	0.70	0.00
Hepatocyte, donor1	11523-119I2	35.11	0.00	0.00	2.42	0.00	2.42	0.00	0.00	2.42	0.00
Hepatocyte, donor2	11603-120I1	30.17	6.46	0.00	5.39	0.00	0.00	0.00	2.15	0.00	1.08
Hepatocyte, donor3	11684-122I1	32.52	6.14	3.07	2.45	0.00	0.61	1.84	0.61	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	21.54	5.22	1.96	0.00	2.61	0.65	0.65	0.00	1.31	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	26.74	12.93	1.57	1.92	1.75	0.87	1.05	0.52	0.17	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	7.41	4.25	0.82	0.82	0.41	0.41	0.00	0.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	9.55	0.00	0.00	3.18	0.00	3.18	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	0.00	6.68	6.68	0.00	6.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	2.77	6.92	0.00	5.54	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	5.01	2.50	2.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	11.87	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	7.69	7.69	0.00	2.56	0.00	2.56	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	4.57	0.00	9.14	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	17.87	3.25	1.62	3.25	0.00	1.62	1.62	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	11.67	3.33	0.00	5.00	0.00	1.67	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	0.00	7.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	13.23	2.65	2.65	3.97	0.00	2.65	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	5.54	1.11	0.00	3.33	0.00	1.11	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	0.00	0.00	10.48	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	6.93	1.89	0.63	3.78	0.00	0.63	0.00	0.00	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	4.64	4.64	0.00	4.64	0.00	4.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	5.17	1.94	0.65	5.17	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	4.83	1.61	0.00	9.66	0.00	3.22	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	23.90	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	4.07	1.63	0.81	10.59	0.00	0.81	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	5.46	2.10	0.00	6.72	0.00	1.26	0.00	0.00	0.00	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	3.21	0.80	0.00	6.43	0.00	3.21	0.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	0.92	0.00	0.92	5.54	0.00	0.92	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	1.89	0.00	0.00	3.30	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	1.81	0.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	29.48	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	4.30	0.00	0.00	6.46	0.00	1.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	3.81	0.00	0.00	7.62	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	16.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	5.10	1.91	0.00	3.83	0.00	3.19	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	3.65	0.00	0.00	7.29	0.00	1.82	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	5.71	2.86	0.00	5.00	0.00	2.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	3.32	0.00	9.95	0.00	3.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	1.23	0.93	0.31	1.85	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	5.27	1.76	0.00	1.76	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	3.14	3.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	2.78	0.70	0.70	5.56	0.00	0.70	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	6.64	4.43	0.00	4.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	3.24	9.73	0.00	3.24	0.00	3.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	3.49	2.62	0.87	6.10	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	13.50	2.25	0.00	2.25	0.00	2.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	6.97	6.97	3.48	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	10.67	3.20	1.07	4.27	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	12.47	0.00	0.00	6.93	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	0.00	2.85	0.00	0.00	0.00	2.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	7.36	0.92	0.92	3.68	0.92	0.92	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	9.08	0.00	0.00	6.05	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	4.23	5.29	1.06	4.23	0.00	3.17	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	6.69	2.45	1.06	0.90	0.24	0.24	0.16	0.08	0.00	0.00
Keratinocyte - epidermal, donor2	11349-117G8	1.76	0.59	0.00	0.00	0.59	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	8.33	2.65	1.51	1.51	0.09	0.38	0.00	0.28	0.19	0.00
Keratinocyte - oral, donor1	11251-116E9	21.91	6.92	1.48	2.27	0.23	0.34	0.11	0.11	0.11	0.00
Keratocytes, donor1	11527-119I6	6.19	1.38	0.00	1.03	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	0.00	0.00	0.00	1.17	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	5.34	1.78	0.20	0.59	0.00	0.79	0.00	0.00	0.20	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	2.20	4.40	2.20	6.59	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	4.31	1.08	0.00	1.08	1.08	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	16.61	9.57	1.50	0.81	1.04	0.12	0.58	0.23	0.23	0.23
Lens Epithelial Cells, donor3	11690-122I7	8.78	4.14	0.40	2.12	0.30	0.00	0.10	0.10	0.10	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	8.06	1.30	0.24	0.83	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	6.14	0.84	0.28	0.28	0.00	0.00	0.28	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	10.86	2.68	0.31	1.57	0.31	0.16	0.00	0.00	0.79	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	6.45	2.15	0.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	2.84	1.26	0.00	0.32	0.00	0.00	0.32	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	3.23	1.51	0.22	0.22	0.11	0.11	0.00	0.11	0.22	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	10.67	0.41	0.00	1.23	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	4.30	0.51	0.00	0.25	0.00	0.25	0.00	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	4.79	1.97	0.70	0.56	0.14	0.28	0.00	0.14	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	5.93	1.98	1.19	1.58	0.00	0.40	0.40	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	6.79	0.39	0.39	0.58	0.19	0.00	0.19	0.39	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	2.41	0.74	0.00	0.19	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	5.23	3.48	0.70	0.35	0.35	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	3.58	1.67	0.48	0.00	0.00	0.00	0.00	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	4.12	1.24	0.14	0.27	0.14	0.14	0.14	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	10.16	1.85	0.00	0.62	0.00	0.00	0.00	0.62	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	2.49	0.31	0.31	0.00	0.00	0.00	0.00	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	3.84	1.46	0.73	0.73	0.18	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	4.94	2.30	0.00	0.66	0.00	0.66	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	3.81	0.59	0.00	0.88	0.00	0.59	0.00	0.00	0.00	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	5.73	0.25	0.25	0.50	0.00	0.25	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	12.12	2.91	0.00	0.00	0.97	0.00	0.00	0.97	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	5.92	0.81	0.54	0.27	0.00	0.00	0.27	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	5.15	1.51	0.91	0.30	0.00	0.15	0.00	0.00	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	8.29	2.59	0.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	9.00	3.14	0.42	0.84	0.00	0.84	0.00	0.21	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	2.41	1.05	0.15	1.20	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	7.57	1.38	0.00	0.69	0.00	0.00	0.00	0.69	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	5.27	1.32	0.19	0.19	0.19	0.19	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	2.54	0.53	0.11	0.11	0.11	0.21	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	8.24	0.48	0.48	0.97	0.48	0.48	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	3.31	0.99	0.33	0.66	0.00	0.66	0.00	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	2.85	0.62	0.25	0.37	0.00	0.00	0.00	0.12	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	18.51	2.59	0.74	0.37	0.37	0.00	0.00	0.00	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	3.71	1.48	0.74	0.25	0.25	0.25	0.00	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	2.89	0.96	0.14	0.41	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	9.01	2.57	0.32	0.00	0.00	0.96	0.00	0.32	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	6.09	1.83	1.52	1.83	0.00	0.30	0.00	0.00	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	8.12	1.96	0.98	0.28	0.14	0.42	0.00	0.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	5.69	1.42	0.71	0.36	0.71	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	1.94	0.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	1.40	0.78	0.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	2.51	0.36	0.36	0.36	0.36	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	1.63	0.65	0.33	0.33	0.00	0.33	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	2.35	0.47	0.00	0.00	0.00	0.00	0.00	0.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	5.69	1.24	0.25	0.50	0.25	0.25	0.00	0.12	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	2.31	1.02	0.00	0.26	0.00	0.51	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	2.09	0.60	0.60	0.00	0.30	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	0.00	2.27	0.00	2.27	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	1.53	0.00	0.00	2.30	0.00	0.00	0.00	0.77	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	0.74	2.23	0.00	0.74	0.00	0.00	0.00	0.00	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	2.96	2.12	0.00	0.42	0.00	0.00	0.42	0.00	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	2.11	0.70	0.00	2.11	0.00	0.70	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	2.80	0.00	0.00	3.74	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	0.52	0.52	0.00	1.55	0.00	0.00	0.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	2.38	1.19	0.00	0.00	0.00	1.19	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	2.04	0.45	0.23	1.13	0.00	0.45	0.23	0.00	0.00	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	2.91	0.58	0.00	2.04	0.00	0.29	0.00	0.29	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	3.15	0.90	0.00	0.90	0.00	0.90	0.00	1.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	2.44	1.22	0.00	0.95	0.14	0.54	0.14	0.00	0.00	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	4.11	1.03	0.51	2.57	0.00	0.51	0.00	0.51	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	1.76	0.71	0.00	1.76	0.00	0.71	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	5.33	0.67	0.00	0.00	0.00	0.00	0.00	1.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	2.55	0.51	0.51	2.04	0.00	0.00	0.00	1.02	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	2.13	1.07	0.00	1.60	0.00	0.80	0.00	0.27	0.00	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	2.83	0.76	0.19	1.32	0.00	0.76	0.19	0.57	0.38	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	4.91	2.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	0.00	0.82	0.00	1.63	0.00	0.00	1.63	0.00	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	2.08	1.46	0.21	1.46	0.00	0.42	0.42	0.62	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	2.24	1.96	0.00	1.12	0.00	0.56	0.28	1.12	0.84	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	0.00	1.03	0.00	2.06	0.00	2.06	1.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	4.06	0.58	0.00	2.03	0.00	0.29	0.00	0.00	0.29	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	0.90	0.30	0.00	2.99	0.00	0.30	0.00	0.30	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	2.21	1.11	0.00	1.11	0.00	0.55	0.00	0.55	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	1.41	0.71	0.00	1.06	0.00	0.35	0.00	0.35	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	0.00	0.37	0.00	1.48	0.00	0.74	0.00	0.00	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	1.15	1.15	0.00	2.30	0.00	2.30	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	3.07	0.00	0.00	0.38	0.00	0.38	0.00	0.77	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	0.57	1.70	0.00	0.57	0.00	0.00	0.00	0.00	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	3.28	1.64	0.00	1.64	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	3.16	0.90	0.00	0.90	0.00	0.00	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	2.15	1.44	0.00	1.44	0.00	0.00	0.00	0.00	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	0.75	1.49	0.00	2.99	0.00	0.00	0.00	0.00	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	1.11	1.11	0.00	2.23	0.00	0.00	0.00	0.00	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	3.88	1.29	0.00	0.00	0.00	0.00	0.00	0.86	0.00	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	0.33	1.33	0.33	1.00	0.33	2.00	0.33	0.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	1.81	1.21	0.00	0.60	0.00	0.00	0.00	0.60	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	2.13	0.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	1.72	2.06	0.00	0.69	0.00	0.69	0.00	0.00	0.69	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	1.61	0.54	0.00	1.07	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	0.00	2.02	0.00	1.35	0.00	0.67	0.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	2.22	1.11	0.00	1.85	0.00	1.11	0.00	0.00	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	4.65	3.49	0.00	2.33	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	1.06	1.06	0.00	1.06	0.00	1.06	1.06	0.00	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	2.00	0.00	0.00	0.40	0.00	0.40	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	2.91	0.73	0.00	0.00	0.73	0.73	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	1.53	0.00	0.00	0.00	0.00	0.77	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	2.47	0.49	0.00	1.48	0.00	0.00	0.00	0.00	0.49	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	1.88	1.88	0.00	2.82	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	1.01	0.50	0.00	2.01	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	3.15	0.90	0.45	0.45	0.00	0.90	0.45	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	5.16	0.00	0.00	1.72	0.00	0.00	1.72	0.00	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	1.78	0.45	0.45	1.34	0.00	0.89	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	1.17	1.56	0.00	1.56	0.00	1.17	0.00	0.00	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	3.96	0.66	0.66	1.32	0.00	0.66	0.00	0.00	0.66	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	2.59	1.56	0.00	2.59	0.00	1.56	0.00	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	4.81	1.31	0.44	3.50	0.00	0.44	0.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	2.80	1.12	0.00	0.00	0.00	0.00	0.00	0.00	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	3.97	1.32	0.00	1.77	0.00	0.44	0.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	3.86	0.77	0.00	2.31	0.00	0.77	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	3.04	2.53	1.01	2.03	0.51	1.52	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	1.44	0.96	0.00	0.96	0.00	0.96	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	3.58	1.19	0.00	1.99	0.00	1.59	0.00	0.40	0.40	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	5.47	1.22	1.22	0.61	0.00	0.00	0.00	0.00	0.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	4.84	0.69	0.00	1.38	0.69	1.38	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	3.42	0.00	0.00	1.90	0.00	0.38	0.00	0.38	1.14	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	5.68	1.55	0.00	2.58	0.52	0.52	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	0.00	0.60	0.00	1.81	0.00	1.21	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	3.17	0.95	0.32	0.32	0.00	1.27	0.00	0.32	1.27	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	2.13	1.07	0.00	3.20	0.00	0.53	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	2.30	0.57	0.57	1.72	0.00	1.15	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	3.60	2.06	0.00	0.51	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	3.54	0.00	0.00	2.12	0.00	0.00	0.00	0.00	0.00	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	1.70	1.13	0.00	2.27	0.00	0.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	2.08	0.00	0.00	1.25	0.00	0.83	0.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	3.13	1.57	0.00	1.57	0.00	0.00	0.00	0.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	2.09	0.42	0.00	1.67	0.00	1.25	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	2.32	0.93	0.00	0.93	0.00	1.86	0.93	0.46	0.00	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	0.67	0.00	0.00	0.67	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	1.07	0.00	0.00	2.14	0.00	0.53	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	2.42	1.21	0.00	1.21	0.00	0.81	0.00	0.00	0.40	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	0.00	0.00	0.00	0.92	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	1.14	0.57	0.00	0.57	0.00	0.57	0.00	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	3.07	0.00	0.77	2.30	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	0.55	1.09	0.55	0.55	0.55	1.09	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	0.89	2.67	0.00	0.45	0.00	0.45	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	2.60	1.82	0.00	0.78	0.00	1.04	0.26	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	3.98	0.66	0.00	1.99	0.00	1.33	0.00	0.66	0.00	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	21.88	11.62	1.14	0.46	1.14	0.23	1.60	0.46	0.00	0.46
Macrophage - monocyte derived, donor2	11313-117C8	16.15	5.69	0.18	0.73	0.18	0.55	0.18	0.18	0.18	0.00
Macrophage - monocyte derived, donor3	11389-118C3	13.50	4.72	0.79	0.52	0.26	0.13	0.00	0.13	0.00	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	6.37	1.06	2.12	0.00	1.06	0.00	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	16.80	6.18	4.28	0.79	1.43	0.16	0.16	0.00	0.00	0.16
Mallassez-derived cells, donor3	11930-125I4	10.56	4.45	2.36	1.67	0.97	0.42	0.00	0.00	0.00	0.14
Mammary Epithelial Cell, donor1	11273-116H4	16.24	4.88	3.79	3.09	0.90	0.90	0.10	0.20	0.30	0.00
Mammary Epithelial Cell, donor2	11350-117G9	10.42	2.90	3.76	2.61	0.87	0.00	0.00	0.00	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	3.24	0.25	0.00	0.75	0.00	0.00	0.00	0.00	0.50	0.00
Mast cell - stimulated, donor1	11487-119E2	431.17	119.32	37.96	2.71	12.20	0.00	5.42	0.68	0.00	5.42
Mast cell, donor1	11563-120D6	13.09	11.46	0.54	0.22	1.08	0.11	0.76	0.32	0.00	0.11
Mast cell, donor2	11565-120D8	251.71	136.11	24.07	1.78	6.24	0.00	2.38	0.30	0.30	2.97
Mast cell, donor3	11566-120D9	229.40	102.21	13.96	1.80	7.88	1.35	5.18	0.45	0.23	2.48
Mast cell, donor4	11567-120E1	162.75	94.50	11.70	1.24	6.03	0.53	2.66	0.71	0.53	0.89
Mast cell, expanded and stimulated, donor5	11940-126A5	24.95	18.52	1.00	0.33	1.22	0.22	0.44	0.33	0.11	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	26.27	18.68	0.00	0.58	1.17	0.58	0.58	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	13.54	9.75	0.46	0.11	1.03	0.23	0.80	0.00	0.46	0.11
Mast cell, expanded, donor8	11941-126A6	27.62	17.07	1.17	0.50	1.00	0.33	0.17	0.33	0.33	0.17
Melanocyte - dark, donor1	11502-119F8	18.11	4.58	1.09	1.39	0.50	0.20	0.00	0.10	0.10	0.10
Melanocyte - dark, donor2	11582-120F7	8.65	1.38	1.73	1.73	0.35	0.35	0.35	0.35	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	2.83	0.80	0.80	0.80	0.36	0.22	0.14	0.07	0.14	0.07
Melanocyte - light, donor1	11274-116H5	3.06	0.71	1.18	0.71	0.47	0.24	0.00	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	0.68	0.68	0.00	1.36	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	2.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	2.92	0.52	0.62	0.42	0.10	0.10	0.00	0.31	0.31	0.21
Melanocyte, donor2 (MC+2)	12739-135I3	5.11	0.54	0.81	0.81	0.00	0.00	0.00	1.34	0.27	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	3.48	0.54	0.80	0.54	0.27	0.27	0.00	0.27	0.00	0.00
Meningeal Cells, donor1	11493-119E8	5.71	2.85	0.00	1.12	0.00	0.50	0.00	0.00	0.00	0.12
Meningeal Cells, donor2	11573-120E7	3.52	0.88	1.32	0.88	0.00	0.44	0.44	0.44	0.00	0.00
Meningeal Cells, donor3	11654-122E7	14.91	4.81	0.73	0.41	0.08	0.57	0.08	0.24	0.33	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	5.70	2.00	0.00	0.86	0.29	0.00	0.00	0.29	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	33.51	7.85	2.62	1.71	1.11	0.10	0.20	0.70	0.20	0.30
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	1.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	2.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	7.18	0.72	0.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	7.20	1.91	0.21	1.06	0.21	0.00	0.21	0.00	0.00	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	5.03	2.51	0.50	1.01	0.50	0.50	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	1.10	0.66	0.22	1.10	0.00	0.44	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	0.73	0.00	0.00	0.73	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	0.82	0.00	0.00	1.23	0.00	0.20	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	11.77	2.63	0.28	2.22	0.42	0.42	0.14	0.00	0.14	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	0.37	0.74	0.37	0.37	0.37	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	8.29	3.16	0.79	1.84	1.18	0.53	0.13	0.26	0.39	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	0.30	0.00	0.00	0.00	0.00	0.00	0.30	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	0.00	0.00	0.00	0.00	2.34	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	0.00	0.00	0.00	1.92	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	7.80	3.54	1.06	1.42	0.35	0.00	0.00	0.00	0.35	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	5.63	2.19	0.31	0.94	0.31	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	0.00	0.00	0.00	0.73	0.00	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	7.96	4.24	2.12	0.00	1.06	0.00	1.33	0.00	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	5.51	2.00	0.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	4.91	2.17	1.81	0.65	0.07	0.07	0.22	0.22	0.43	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	6.75	0.00	1.35	0.00	0.00	1.35	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	12.07	3.94	1.97	0.00	0.49	0.00	0.49	0.25	0.25	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	7.95	2.94	0.00	1.47	0.29	0.88	0.00	0.29	0.59	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	9.30	6.20	1.24	0.62	0.93	0.31	0.62	0.31	0.31	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	6.43	2.07	0.41	0.00	0.21	0.21	0.21	0.62	0.21	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	2.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	16.02	4.50	1.00	0.25	0.75	0.25	0.75	0.75	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	9.78	2.33	0.00	0.00	0.00	0.00	0.00	0.93	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	10.36	4.27	1.02	0.00	0.61	0.00	0.20	0.61	0.41	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	6.73	2.38	0.40	1.58	0.79	0.00	0.00	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	18.58	4.42	0.88	0.88	0.00	0.00	0.00	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	8.74	3.04	0.38	0.38	0.38	0.38	0.00	0.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	3.95	0.00	0.00	1.32	0.00	1.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	17.40	4.46	0.64	0.00	0.42	0.64	0.00	0.42	0.42	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	0.92	1.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	11.62	3.58	1.19	0.30	0.30	0.89	0.00	0.89	0.60	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	5.03	0.00	1.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	16.81	6.27	1.51	0.25	0.50	0.00	0.25	0.50	0.50	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	4.99	2.85	0.00	0.24	0.00	0.00	0.00	0.00	0.24	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	2.76	0.55	0.55	0.55	0.55	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	18.65	5.76	0.69	0.46	0.00	0.23	0.23	0.69	0.23	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	2.31	1.26	0.00	0.42	0.00	0.00	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	4.08	1.22	0.00	0.00	0.20	0.20	0.20	0.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	12.87	2.57	1.07	0.00	0.00	0.21	0.00	0.43	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	2.89	1.33	0.00	0.22	0.00	0.00	0.00	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	7.23	3.07	0.66	0.00	0.44	0.00	0.00	0.44	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	2.03	0.00	0.00	0.51	0.51	0.51	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	5.71	1.90	0.82	0.00	0.27	0.00	0.00	0.00	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	5.29	1.47	0.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	2.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	3.36	1.92	0.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	5.60	2.00	0.00	0.00	0.00	0.40	0.00	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	2.00	4.00	0.00	0.00	0.00	0.00	0.00	0.50	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	2.63	1.31	1.31	0.44	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	3.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	2.56	0.00	0.00	1.28	0.00	0.00	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	4.21	2.98	1.74	0.25	0.00	0.00	0.00	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	1.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2.21	0.00	0.00	2.21	0.00	0.00	0.00	0.00	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	6.15	1.71	1.71	0.00	0.00	0.00	0.00	0.34	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	2.63	0.44	0.00	0.44	0.00	0.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	1.42	1.42	0.00	0.00	0.00	0.71	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	5.05	3.37	1.12	0.28	0.00	0.00	0.00	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	4.16	2.91	0.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	1.17	0.58	0.00	0.58	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	5.43	1.51	0.60	0.60	0.00	0.00	0.00	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	4.17	5.01	1.25	1.67	0.00	0.83	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	7.22	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	5.54	0.92	2.77	1.85	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	5.69	4.55	1.14	0.57	0.00	1.14	0.00	0.00	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	5.53	2.63	0.97	0.14	0.00	0.28	0.00	0.14	0.28	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	8.03	3.37	0.52	1.04	0.00	0.00	0.00	0.26	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	5.15	3.86	0.43	0.86	0.00	0.43	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	1.27	1.27	0.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	6.41	2.40	1.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	6.29	5.39	1.20	0.60	0.30	0.90	0.00	0.00	0.30	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	2.83	2.26	0.42	0.14	0.00	0.14	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	8.60	1.91	0.64	0.32	0.00	0.00	0.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	9.07	4.42	1.55	0.88	0.22	0.22	0.00	0.22	0.44	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	2.28	1.52	0.76	0.00	0.00	0.38	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	10.23	5.40	1.99	0.57	0.85	0.28	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	13.76	5.90	2.21	0.49	0.25	0.49	0.25	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	2.61	4.56	0.65	0.65	0.65	0.65	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	7.06	4.12	1.18	0.00	0.00	0.00	0.00	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	9.80	6.05	2.31	0.58	0.00	0.29	0.00	0.00	0.29	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	14.84	8.24	4.53	0.41	0.82	0.00	0.00	0.00	0.82	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	4.17	4.76	0.89	1.19	0.00	0.60	0.30	0.60	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	15.07	3.77	0.00	0.00	0.00	0.00	0.00	3.77	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	3.56	5.35	1.78	0.00	0.00	0.00	0.00	0.00	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	16.10	5.91	1.97	0.00	0.66	0.00	0.99	0.33	0.00	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	11.57	3.16	2.10	0.00	0.00	0.00	0.00	1.05	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	16.21	7.91	0.99	0.40	2.17	0.40	0.79	0.20	0.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	5.59	8.38	0.00	0.00	0.93	0.00	0.00	0.00	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	12.39	4.13	1.50	0.00	0.00	0.38	0.38	0.75	0.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	3.73	3.73	0.27	0.00	0.27	0.00	0.27	0.00	0.53	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	18.21	9.73	1.02	0.11	0.34	0.00	0.57	0.11	0.23	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	13.26	2.21	0.74	0.00	0.74	0.00	0.00	0.74	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	16.12	4.03	1.47	0.00	0.73	0.00	1.10	0.37	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	9.33	3.11	1.56	0.00	1.56	0.00	0.00	4.67	4.67	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	19.24	4.81	1.07	0.53	0.00	0.53	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	16.16	2.02	0.00	0.00	0.00	0.00	0.00	2.02	2.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	7.59	2.11	0.42	0.00	0.84	0.42	0.00	0.00	1.26	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	46.31	19.07	2.72	0.00	4.09	1.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	25.43	6.99	1.27	0.00	0.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	25.91	13.77	4.05	0.81	0.00	0.00	0.00	0.00	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	25.68	10.57	3.02	6.04	1.51	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	199.86	125.62	5.71	5.71	0.00	5.71	5.71	0.00	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	257.73	78.30	22.84	6.52	3.26	3.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	28.51	33.27	4.75	0.00	0.00	0.00	4.75	0.00	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	0.00	0.00	0.00	0.00	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	11.42	3.02	0.65	1.29	0.00	0.43	0.00	0.22	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	9.93	4.18	1.05	0.52	0.52	0.00	0.00	2.09	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	7.34	0.00	1.33	0.00	0.00	0.00	0.00	0.67	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	4.17	0.42	0.42	0.00	0.42	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	15.78	2.47	3.99	0.57	0.57	0.00	0.00	0.95	0.38	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	9.58	1.60	1.60	1.60	1.60	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	2.72	0.00	0.68	0.00	0.00	0.68	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	16.54	3.68	7.35	0.00	1.84	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	7.95	1.26	2.09	0.00	0.00	0.84	0.84	1.26	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	6.28	1.16	0.70	0.70	0.23	0.46	0.00	0.70	0.00	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	8.11	2.43	0.54	0.00	0.00	0.00	0.27	0.54	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	13.03	3.78	1.05	0.21	0.63	0.21	0.00	0.42	0.00	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	44.54	22.27	0.00	22.27	0.00	0.00	0.00	0.00	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	6.95	1.49	0.50	0.00	0.50	0.00	0.50	0.99	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	8.93	3.25	1.62	0.54	0.00	0.00	0.00	1.35	0.27	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	7.48	1.59	0.68	0.23	0.45	0.00	0.00	0.45	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	4.25	1.96	0.33	0.16	0.16	0.33	0.00	0.33	0.16	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	13.30	4.01	2.37	0.36	0.91	0.00	0.18	0.00	0.55	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	10.61	2.65	1.06	0.53	0.53	0.53	0.00	1.06	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	6.60	0.60	1.20	0.00	0.60	0.00	0.00	0.00	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	23.96	5.91	2.30	1.31	1.31	0.00	0.66	0.98	0.66	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	4.88	1.63	0.00	0.33	0.33	0.16	0.00	0.33	0.16	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	16.76	3.00	2.82	0.18	0.35	0.35	0.18	0.00	0.71	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	4.92	2.81	1.41	0.00	0.00	0.00	0.00	0.00	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	6.44	2.76	0.46	0.00	0.00	0.00	1.38	1.38	1.38	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	9.96	1.29	2.25	0.64	0.00	0.00	0.64	0.64	0.64	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	21.73	4.48	5.86	0.69	1.72	0.00	1.03	3.45	1.38	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	53.10	10.11	10.11	0.00	0.00	0.00	0.00	2.53	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	10.92	2.90	1.11	0.00	0.22	0.00	0.45	0.45	0.45	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	5.08	2.12	0.42	0.85	0.42	0.00	0.00	0.85	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	5.46	2.14	0.71	0.24	0.00	0.00	0.00	0.71	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	9.87	0.43	1.29	1.29	0.43	0.43	0.00	0.43	0.00	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	99.31	36.11	18.06	0.00	0.00	0.00	0.00	0.00	18.06	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	6.66	1.33	0.67	0.33	0.00	0.00	0.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	7.21	2.25	3.16	0.00	0.45	0.45	0.45	0.45	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	10.71	1.59	0.79	0.00	0.00	0.79	0.40	1.19	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	0.93	3.71	3.71	0.00	0.93	0.00	0.93	1.86	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	7.95	3.03	1.89	0.76	0.38	0.76	0.38	0.76	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	5.54	1.96	0.65	0.33	0.65	0.00	0.00	0.65	0.65	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	5.67	0.00	0.00	0.44	0.00	0.44	0.44	1.31	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	12.21	2.71	1.81	0.90	0.00	0.45	0.00	0.90	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	14.11	1.76	0.88	0.00	0.00	0.00	0.00	1.76	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	7.31	0.66	1.99	0.00	0.00	0.00	0.00	0.66	0.66	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	10.42	4.96	0.00	0.50	0.00	0.00	1.98	1.98	0.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	3.83	1.91	0.00	0.77	0.77	0.00	0.38	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	12.40	2.42	0.30	1.21	0.30	1.21	0.00	0.60	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	13.92	4.20	1.55	0.66	0.66	0.22	0.66	0.00	0.44	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	6.10	2.71	2.03	1.36	0.00	0.00	0.00	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	40.88	20.44	5.11	0.00	5.11	0.00	5.11	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	7.32	1.22	0.61	0.00	0.00	0.00	0.00	0.00	1.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	3.46	0.31	0.94	1.89	0.31	0.31	0.31	0.63	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	4.54	0.91	0.91	0.61	0.30	0.30	0.30	1.21	0.00	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	9.49	3.16	2.37	0.00	0.79	0.00	0.00	1.58	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	17.00	3.40	5.67	0.00	2.27	0.00	1.13	4.53	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	60.69	20.23	5.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	9.44	1.99	1.37	0.99	0.50	0.25	0.00	0.25	0.25	0.12
Myoblast, donor2	11322-117D8	7.10	1.92	0.96	0.77	0.38	0.00	0.19	0.38	0.96	0.00
Myoblast, donor3	11398-118D3	16.82	3.20	4.71	2.02	0.84	0.00	0.00	0.34	0.17	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	7.44	4.52	1.17	0.44	0.58	0.29	0.29	0.00	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	292.14	189.43	67.35	2.77	30.75	1.23	0.92	1.54	1.54	4.00
Natural Killer Cells, donor2	11311-117C6	201.74	109.77	66.95	1.81	20.20	0.30	2.41	6.63	5.13	1.51
Natural Killer Cells, donor3	11387-118C1	194.73	105.28	51.90	1.84	15.09	0.92	0.74	3.87	2.58	1.47
Neural stem cells, donor1	11275-116H6	52.26	7.98	14.88	5.08	4.36	0.00	1.45	1.45	1.45	0.73
Neural stem cells, donor2	11352-117H2	71.25	23.11	17.33	9.63	7.70	1.93	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	18.21	6.83	4.55	4.55	3.41	1.14	0.00	3.41	1.14	0.00
Neurons, donor2	11574-120E8	18.05	6.16	4.40	2.20	2.42	0.66	0.66	0.00	0.44	0.44
Neurons, donor3	11655-122E8	14.80	5.76	4.93	1.64	1.64	2.47	0.82	7.40	3.29	0.00
Neutrophils, donor1	11233-116C9	850.05	268.19	31.55	4.64	20.42	1.86	1.86	25.06	11.14	0.93
Neutrophils, donor2	11314-117C9	620.36	182.63	23.19	11.60	11.60	5.80	8.70	55.08	20.29	0.00
Neutrophils, donor3	11390-118C4	1871.62	594.35	58.64	9.77	23.82	7.94	2.44	15.27	11.00	3.05
Nucleus Pulposus Cell, donor1	11252-116F1	16.86	5.11	0.47	0.95	0.83	0.59	0.36	0.59	0.24	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	8.14	1.95	0.00	1.30	0.00	0.00	0.33	0.33	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	10.03	3.81	0.60	1.20	0.40	0.00	0.00	0.40	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	6.47	2.20	0.28	1.24	0.28	0.28	0.55	1.38	1.38	0.14
Olfactory epithelial cells, donor2	11934-125I8	8.54	2.46	2.03	1.16	0.58	0.43	0.29	1.16	1.59	0.14
Olfactory epithelial cells, donor3	11935-125I9	5.11	2.16	0.45	1.36	0.57	0.45	0.45	0.34	0.45	0.00
Olfactory epithelial cells, donor4	11936-126A1	7.11	3.31	0.78	2.63	0.29	0.29	0.68	0.58	0.39	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	7.82	3.01	0.00	3.01	0.60	1.20	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	5.74	0.64	0.00	0.00	0.21	0.21	0.43	0.00	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	3.43	1.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	1.86	1.86	1.86	0.62	0.00	0.00	0.00	0.00	0.62	0.00
Osteoblast, donor1	11277-116H8	2.35	0.98	0.20	0.78	0.00	0.20	0.00	0.00	0.00	0.00
Osteoblast, donor2	11354-117H4	8.43	5.62	0.00	2.11	0.70	0.70	0.00	1.40	0.00	0.00
Osteoblast, donor3	11426-118G4	1.60	0.36	0.18	0.71	0.00	0.53	0.00	0.00	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	12.13	3.87	0.93	1.35	0.17	0.59	0.25	0.25	0.17	0.00
Pericytes, donor1	11491-119E6	2.34	1.22	0.11	1.45	0.00	0.00	0.11	0.00	0.00	0.00
Pericytes, donor2	11571-120E5	2.04	1.13	0.45	1.81	0.00	0.45	0.00	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	1.42	0.61	0.20	1.63	0.20	0.00	0.00	0.00	0.00	0.00
Perineurial Cells, donor1	11499-119F5	14.24	3.73	0.68	1.58	0.23	0.57	0.00	0.11	0.00	0.00
Perineurial Cells, donor2	11579-120F4	18.13	5.06	2.21	2.48	0.46	0.55	0.09	0.00	0.18	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	275.71	146.94	21.99	1.91	18.49	0.32	1.27	1.91	0.00	1.27
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	274.74	92.31	30.12	2.69	8.57	0.98	1.71	4.90	3.67	1.22
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	128.25	54.10	10.22	2.46	4.40	0.78	0.39	2.20	0.65	0.78
Placental Epithelial Cells, donor1	11278-116H9	1.67	0.96	0.00	0.24	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	0.98	0.20	0.00	0.20	0.00	0.20	0.00	0.20	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	0.95	0.63	0.00	0.00	0.32	0.63	0.00	0.00	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	3.94	1.88	1.50	1.13	0.75	0.19	0.56	0.00	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	4.70	2.35	0.78	3.13	0.39	1.17	0.26	0.26	0.26	0.26
Preadipocyte - breast, donor2	11328-117E5	1.80	0.45	0.23	1.13	0.23	0.00	0.23	0.23	0.45	0.00
Preadipocyte - omental, donor1	11468-119C1	7.14	2.02	1.60	1.17	0.43	0.21	0.21	0.11	0.11	0.11
Preadipocyte - omental, donor2	11329-117E6	2.62	3.06	0.44	0.44	0.44	0.00	0.00	0.00	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	4.01	1.00	0.57	1.00	0.29	0.43	0.00	0.14	0.43	0.00
Preadipocyte - perirenal, donor1	11469-119C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	6.45	1.84	1.54	0.61	0.00	0.00	0.00	0.00	0.00	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	12.93	2.48	3.36	1.06	0.18	0.71	0.00	0.89	0.53	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	5.96	1.19	0.85	0.85	0.34	0.00	0.00	0.17	0.17	0.00
Preadipocyte - visceral, donor1	11280-116I2	13.13	3.45	3.91	1.58	0.75	0.28	0.00	0.00	0.19	0.00
Preadipocyte - visceral, donor2	11357-117H7	17.95	3.22	4.14	0.92	0.00	0.00	0.00	0.00	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	6.27	1.15	1.99	0.73	0.31	0.42	0.00	0.63	0.21	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	15.54	5.58	1.36	2.41	0.60	0.60	0.30	0.60	0.75	0.15
Prostate Epithelial Cells, donor2	11331-117E8	4.06	2.71	0.81	0.81	0.14	0.00	0.00	0.27	0.54	0.00
Prostate Epithelial Cells, donor3	11404-118D9	15.43	3.92	1.71	0.43	0.31	0.31	0.06	0.73	0.43	0.00
Prostate Stromal Cells, donor1	11254-116F3	5.13	1.94	0.68	0.46	0.34	0.23	0.11	0.11	0.00	0.00
Prostate Stromal Cells, donor2	11332-117E9	8.43	1.79	0.54	1.08	0.00	0.18	0.00	1.26	0.00	0.00
Prostate Stromal Cells, donor3	11405-118E1	3.44	0.42	0.21	0.83	0.73	0.31	0.10	0.21	0.42	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	2.92	1.82	0.00	0.36	0.00	0.00	0.00	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	11.71	9.08	0.76	0.90	0.14	0.28	0.00	0.21	0.21	0.07
Renal Epithelial Cells, donor1	11517-119H5	1.52	0.51	0.00	3.04	0.00	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	1.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	17.57	8.15	0.53	1.91	0.53	0.21	0.00	0.32	0.53	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	4.09	0.68	0.68	0.00	0.00	0.68	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	4.58	0.94	0.00	0.67	0.00	0.13	0.00	0.13	0.00	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	9.55	2.44	0.44	1.33	0.22	0.44	0.22	0.67	0.67	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	0.67	1.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	1.76	0.44	0.00	0.44	0.22	0.44	0.00	0.00	0.00	0.22
Renal Mesangial Cells, donor2	11598-120H5	0.00	0.00	0.63	1.25	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	0.00	0.28	0.00	0.83	0.00	0.28	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	3.22	1.88	0.00	0.27	0.00	0.00	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	0.84	0.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	1.93	1.16	0.19	0.58	0.00	0.39	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	7.26	2.85	0.78	1.56	0.26	0.00	0.00	0.26	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	3.70	3.13	0.00	0.57	0.28	0.28	0.28	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	3.09	1.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	29.86	7.78	2.26	1.51	0.50	0.00	0.00	0.00	1.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	46.10	11.89	4.41	4.41	2.14	1.20	8.02	0.53	0.67	2.94
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	4.47	5.36	0.89	0.89	1.79	0.00	0.89	0.00	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	23.12	5.50	2.20	3.30	1.65	0.00	2.20	1.10	1.10	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	13.92	4.64	2.90	1.16	1.74	1.74	1.74	0.00	0.58	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	13.26	5.59	1.56	2.08	0.65	0.78	0.65	0.00	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	5.36	3.97	0.50	1.19	0.30	0.50	0.30	0.60	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	8.03	5.02	1.34	1.90	1.12	0.11	0.22	0.22	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	9.92	3.60	0.50	2.48	1.12	0.50	0.62	0.37	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	6.41	3.26	1.40	1.17	0.47	0.35	0.23	0.82	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	9.94	4.39	0.69	2.54	1.62	0.23	0.00	0.23	0.92	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	5.61	2.46	0.96	1.10	0.82	1.23	0.41	0.41	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	6.50	2.87	1.66	0.61	0.45	0.30	0.00	0.30	1.66	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	5.20	5.20	0.36	2.33	0.54	0.36	0.36	0.18	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	5.59	3.16	0.57	1.00	0.14	0.57	0.00	0.57	0.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	6.12	3.22	0.64	1.72	0.54	0.11	0.32	0.54	0.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	7.52	2.88	0.89	1.33	1.11	0.22	0.44	0.66	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	7.26	2.68	1.72	1.34	0.57	0.96	0.38	0.19	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	5.12	3.54	1.96	1.96	0.56	0.56	0.28	0.37	0.47	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	14.66	7.70	2.25	2.25	1.69	0.38	0.19	0.38	0.38	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	7.17	3.72	1.59	1.73	0.53	0.66	0.13	0.53	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	5.45	4.48	1.65	2.14	0.68	0.88	0.29	0.58	0.29	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	8.02	2.67	1.72	2.29	0.57	0.76	0.00	0.95	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	5.98	3.74	0.75	2.03	0.53	0.53	0.00	0.75	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	10.93	2.80	0.84	1.12	0.56	0.84	0.28	0.84	0.56	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	6.15	2.91	0.34	2.05	0.68	0.85	0.00	0.17	0.51	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	4.38	1.64	0.91	2.01	0.36	0.91	0.00	0.73	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	6.62	3.07	1.59	1.59	0.86	0.49	0.61	0.61	0.49	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	3.63	2.42	0.67	2.42	0.40	0.81	0.00	0.67	0.54	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	7.78	3.30	0.94	1.42	0.24	0.71	0.24	0.71	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	6.15	2.18	1.59	2.98	0.60	0.20	0.40	1.59	0.79	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	4.68	1.40	1.64	2.81	0.70	1.17	0.23	0.23	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	3.53	2.28	1.24	1.66	0.00	0.41	0.00	0.62	0.41	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	8.41	4.87	1.77	3.32	1.11	0.66	0.22	0.44	1.55	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	3.76	1.46	0.63	1.88	0.63	0.84	0.00	0.21	0.42	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	4.85	2.42	0.94	1.21	0.54	0.40	0.27	0.81	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	3.92	1.02	1.19	2.38	0.34	0.51	0.17	0.51	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	2.89	2.70	0.58	1.35	0.39	0.77	0.00	0.96	0.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	7.39	4.99	1.55	0.69	0.00	1.03	0.00	0.17	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	4.80	1.78	0.69	1.23	0.14	0.27	0.27	1.10	0.27	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	6.73	3.61	0.99	1.97	1.31	0.16	0.00	0.49	0.33	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	6.14	2.90	1.02	1.19	1.36	0.68	0.34	1.19	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	6.21	2.37	0.89	1.78	1.33	0.59	0.15	0.44	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	4.26	2.93	1.07	1.33	0.80	0.53	0.53	0.53	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	7.60	3.46	1.80	3.46	0.83	1.11	0.28	0.00	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	5.00	0.95	0.71	0.95	0.24	1.43	0.00	0.48	0.95	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	7.66	4.43	1.81	2.42	1.01	1.01	0.00	0.40	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	5.93	2.64	1.04	2.45	0.47	0.38	0.19	0.28	0.28	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	10.13	2.45	2.79	2.45	0.70	0.35	1.05	0.35	1.75	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	7.25	1.81	1.81	2.12	0.60	1.21	1.21	0.00	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	5.14	2.20	0.61	3.06	0.73	1.22	0.49	0.37	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	22.27	11.21	4.66	7.71	3.06	2.04	1.89	0.44	0.58	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	10.95	4.87	0.61	4.87	0.61	0.61	0.00	0.61	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	4.52	2.71	0.30	0.90	0.90	0.00	0.30	1.51	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	5.43	3.85	0.90	3.39	0.23	0.90	0.23	1.36	0.90	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	10.78	4.79	1.20	5.99	0.60	2.40	0.00	0.90	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	7.56	2.48	0.94	2.72	0.47	1.06	0.35	0.35	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	8.96	2.99	0.85	1.28	0.85	0.64	0.21	0.64	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	14.42	3.00	3.00	5.41	1.80	3.00	0.60	0.60	0.00	0.00
Schwann Cells, donor1	11498-119F4	0.56	0.38	0.00	0.94	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor2	11578-120F3	6.80	6.80	0.00	3.40	0.00	0.00	0.00	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	7.45	2.63	0.88	0.66	0.44	0.00	0.22	0.44	0.00	0.00
Sebocyte, donor1	11220-116B5	2.19	1.10	0.55	1.64	0.00	0.00	0.00	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	0.92	0.92	1.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	1.24	0.41	0.00	0.21	0.21	0.62	0.00	0.00	0.00	0.00
Sertoli Cells, donor1	11255-116F4	8.28	0.00	1.66	1.66	0.00	0.00	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	2.82	0.00	0.00	2.82	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	15.57	4.93	1.58	0.88	0.26	0.09	0.00	0.18	0.00	0.00
Skeletal Muscle Cells, donor2	11358-117H8	4.34	0.72	0.00	0.72	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	5.85	2.51	0.00	0.00	0.84	0.84	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	10.37	4.56	0.47	4.24	0.47	0.47	0.16	0.31	0.16	0.00
Skeletal Muscle Cells, donor5	11455-119A6	11.00	2.53	0.59	4.01	0.15	1.04	0.30	0.59	0.45	0.00
Skeletal Muscle Cells, donor6	11459-119B1	15.54	4.46	2.00	5.39	0.00	1.23	0.15	0.15	0.15	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	31.12	9.70	1.26	8.06	1.01	1.39	0.50	0.63	0.25	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	12.27	2.28	1.00	6.85	0.14	1.28	0.00	0.57	0.86	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	10.91	4.17	0.99	3.67	0.50	0.89	0.20	0.20	0.40	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	19.63	5.90	1.85	1.60	0.25	0.08	0.08	0.08	0.51	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	7.24	0.72	0.72	0.00	0.00	0.00	0.00	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	3.99	0.69	0.28	0.83	0.14	0.28	0.00	0.14	0.00	0.00
Skin - palm, donor1	10286-104F7	0.00	8.06	0.00	2.69	0.00	2.69	0.00	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	3.32	1.73	0.29	0.43	0.00	0.29	0.00	0.43	0.14	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	120.23	64.61	18.81	19.63	4.09	4.09	1.64	8.18	0.82	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	2.60	1.82	0.39	0.91	0.00	0.13	0.00	0.39	0.13	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	20.85	6.53	2.50	0.83	0.56	0.00	0.14	0.14	0.42	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	9.56	2.11	2.53	1.55	0.00	0.42	0.00	0.42	0.56	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	98.32	35.31	14.38	20.93	1.69	9.09	0.21	1.27	0.42	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	12.52	3.30	1.35	1.20	0.15	0.60	0.00	0.82	0.30	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	1.23	0.31	0.31	0.31	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	18.01	6.67	6.45	2.89	2.00	0.67	0.00	0.00	0.22	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	5.29	4.11	0.59	1.18	0.59	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	3.54	1.33	1.10	0.88	0.00	0.00	0.22	0.22	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	1.97	0.00	0.79	0.00	0.39	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	4.64	2.32	0.77	0.77	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	3.00	0.00	1.00	4.00	1.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	3.73	1.06	0.80	0.13	0.00	0.00	0.00	0.13	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	6.65	2.66	1.11	1.11	0.22	0.22	0.22	0.89	0.00	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	6.27	3.58	1.02	1.66	0.38	0.77	0.00	0.13	0.00	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	9.44	3.26	0.33	1.95	0.33	0.00	0.00	0.65	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	13.58	7.97	0.30	2.95	1.18	0.59	0.00	0.30	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	5.27	1.42	0.14	2.42	0.00	0.85	0.14	0.43	0.28	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	0.81	0.33	0.33	0.33	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	3.65	1.22	0.30	2.44	0.00	0.30	0.00	0.30	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	3.54	2.27	0.25	1.01	0.25	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	6.12	6.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	4.77	0.00	0.95	0.95	0.00	0.48	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	9.29	4.42	0.44	2.51	0.29	0.74	0.15	0.15	0.15	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	6.67	1.51	0.65	2.80	0.00	1.29	0.22	1.08	0.43	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	6.72	2.52	0.63	2.52	0.31	0.63	0.10	0.31	0.31	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	1.55	0.15	0.77	0.00	0.15	0.15	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	2.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	2.39	0.60	0.60	0.30	0.30	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	1.71	0.68	0.34	0.68	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	12.01	6.05	1.81	1.57	1.02	0.47	0.71	0.08	0.31	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	5.64	2.82	0.81	0.81	0.20	0.20	0.00	0.10	0.00	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	8.42	1.37	2.28	0.91	0.46	0.00	0.00	0.23	0.23	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	1.21	0.00	0.60	0.60	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	8.48	2.38	0.79	1.32	0.53	0.26	0.26	0.26	0.26	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	9.59	2.93	0.93	1.33	0.27	0.40	0.00	0.00	0.27	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	5.13	1.13	1.63	0.50	0.63	0.25	0.25	0.75	0.63	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	5.33	3.30	0.00	1.52	0.76	0.25	0.25	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	4.82	1.36	0.15	0.60	0.00	0.00	0.00	0.00	0.00	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	3.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	1.29	1.29	0.00	1.29	0.00	1.29	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	5.12	0.93	0.00	0.93	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	4.54	1.01	0.50	2.02	1.01	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	3.13	0.94	0.63	0.31	0.00	0.00	0.00	0.31	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	0.29	0.00	0.00	0.29	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	10.33	2.33	0.33	1.25	0.00	0.17	0.08	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	11.21	2.80	0.47	0.47	0.00	0.00	0.00	0.00	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	2.59	1.15	0.58	0.58	0.14	0.43	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	7.90	3.31	0.51	0.51	0.51	0.00	0.00	0.00	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	1.13	0.19	0.19	0.38	0.00	0.56	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	6.71	3.21	0.42	0.70	0.28	0.28	0.00	0.14	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	2.35	1.51	0.34	0.50	0.25	0.17	0.08	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	2.45	0.24	0.73	0.24	0.00	0.00	0.00	0.00	0.00	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	6.85	1.33	1.77	1.55	0.44	0.88	0.00	0.22	0.00	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	23.99	6.44	6.44	0.59	0.88	0.88	0.00	0.29	0.29	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	5.44	1.75	1.17	1.36	0.00	0.00	0.58	0.78	0.19	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	8.20	1.59	1.59	0.79	0.00	0.00	0.26	1.32	0.00	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	7.07	1.49	0.74	0.37	0.00	0.00	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	5.75	2.87	0.72	1.44	0.00	0.00	0.36	1.08	0.36	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	2.84	1.14	1.14	0.85	0.00	0.00	0.00	0.00	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	6.70	1.18	1.18	0.79	0.39	0.00	0.00	0.39	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	7.11	3.30	2.29	0.51	0.00	0.25	0.00	0.25	0.25	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	2.40	3.59	0.40	0.80	0.40	1.20	0.40	1.20	0.80	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	4.60	0.84	2.09	0.42	0.42	0.42	0.42	0.00	1.25	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	6.42	1.83	0.92	0.00	0.00	0.00	0.46	0.92	0.00	0.00
Synoviocyte, donor1	11291-117A4	3.20	1.18	0.67	2.86	0.17	0.17	0.00	0.50	0.00	0.00
Synoviocyte, donor2	11368-117I9	2.18	0.50	0.17	0.50	0.00	0.00	0.34	0.67	0.00	0.17
Synoviocyte, donor3	11440-118H9	2.01	0.89	0.00	0.22	0.00	0.22	0.22	0.89	0.67	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	2.14	1.43	0.00	0.71	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	3.96	0.00	1.98	3.96	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	3.24	0.00	0.69	0.93	0.23	0.00	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	7.46	2.29	1.15	0.93	0.29	0.36	0.00	0.00	0.00	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	1.93	0.77	0.39	0.39	0.00	0.00	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	4.58	0.00	0.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	41.34	9.96	3.81	4.55	1.48	2.09	7.01	0.74	0.37	3.44
Urethra, donor2	10319-105A4	7.19	1.80	1.80	8.99	3.60	1.80	5.40	10.79	0.00	1.80
Urothelial Cells, donor1	11520-119H8	0.53	0.00	0.27	0.53	0.00	0.27	0.00	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	0.80	0.80	0.40	1.60	0.00	0.40	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	1.38	0.23	0.00	1.38	0.00	0.46	0.00	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	9.58	7.58	0.22	3.57	0.22	0.22	0.00	0.00	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	245.58	93.43	8.01	1.78	1.78	0.00	0.89	1.78	0.00	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	297.36	94.35	7.15	2.86	5.72	0.00	0.00	2.86	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	151.28	39.02	4.79	3.42	2.05	2.74	0.00	4.79	2.05	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	180.09	69.90	6.20	3.10	4.48	0.34	1.03	0.00	0.34	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	204.52	85.41	5.81	1.74	8.72	0.00	0.58	0.58	2.32	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	271.76	98.92	9.37	6.25	4.16	0.00	1.04	1.04	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	304.71	102.79	5.51	2.75	4.59	0.92	0.92	3.67	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	152.45	39.25	3.65	1.83	2.74	1.83	1.83	2.74	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	8.02	2.34	3.08	2.84	0.62	1.11	0.25	0.62	0.25	0.37
Wilms' tumor cell line:HFWT	10597-108E3	8.80	1.76	0.88	4.40	0.00	0.88	0.00	1.76	0.00	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	20.39	5.87	0.84	5.59	0.28	1.96	0.28	0.28	0.00	0.28
achilles tendon, donor2	10292-104G4	45.46	14.47	10.33	4.13	0.00	2.07	0.00	10.33	4.13	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	48.44	11.73	2.55	2.04	0.51	0.51	0.76	1.27	0.76	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	60.13	10.45	2.32	1.39	0.46	0.70	0.46	0.00	0.00	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	32.88	12.70	2.49	2.26	0.95	1.78	0.12	0.95	0.36	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	19.32	5.44	1.36	1.36	0.00	0.54	0.00	0.54	0.54	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	16.58	4.50	0.84	0.28	0.00	0.28	0.00	0.28	0.56	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	33.20	11.21	0.63	1.27	0.63	0.63	1.06	0.00	0.63	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	53.35	14.43	4.36	4.63	1.36	1.91	0.00	0.54	0.82	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	100.47	23.79	4.85	5.29	1.32	0.00	0.00	0.88	1.32	1.32
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	59.62	22.46	1.63	1.23	0.00	0.82	0.82	0.41	3.27	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	45.04	12.43	2.72	3.49	1.55	1.94	0.39	1.94	1.55	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	6.07	4.05	0.55	0.00	0.00	0.18	0.18	0.74	0.18	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	27.30	11.70	3.90	15.60	3.90	0.00	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	22.08	7.44	0.46	1.39	0.70	0.23	0.00	0.70	1.63	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	16.31	8.80	1.04	0.26	0.78	0.00	0.26	0.26	1.04	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	19.58	9.06	0.88	0.29	0.88	0.58	0.00	0.58	1.46	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	97.60	19.52	6.04	1.86	1.39	0.00	1.86	0.46	0.46	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	12.75	3.70	1.23	1.65	0.00	0.41	0.00	0.00	0.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	7.67	2.15	0.61	1.53	0.92	0.00	0.00	3.68	0.00	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	87.05	21.76	5.97	3.84	2.13	0.43	1.28	1.28	0.00	1.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	116.77	24.87	6.67	2.12	3.64	0.30	2.43	1.21	0.91	0.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	152.61	34.90	12.52	3.37	3.13	0.72	5.54	2.17	0.72	0.96
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	11.81	3.79	0.45	0.00	0.45	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	6.34	3.34	0.00	6.34	0.33	0.67	0.00	0.33	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	1.86	1.86	0.00	11.15	0.00	1.86	0.00	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	16.20	5.27	0.75	3.01	0.00	0.38	0.00	0.75	0.38	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	11.34	5.23	0.00	3.05	0.87	0.87	0.00	0.44	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	3.75	3.75	0.00	0.00	0.00	1.87	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	14.37	5.89	0.94	2.83	0.00	0.94	0.00	0.47	0.47	0.00
adipose tissue, adult, pool1	10010-101C1	51.19	13.65	4.96	7.76	0.93	2.02	1.71	0.62	0.62	0.62
adipose, donor1	10184-103D4	9.38	7.04	24.04	4.69	7.62	1.76	0.00	2.35	1.17	0.00
adipose, donor2	10185-103D5	9.33	4.46	6.89	4.06	0.81	1.62	0.41	3.24	0.41	0.00
adipose, donor3	10186-103D6	18.24	8.99	7.90	3.27	2.18	1.36	0.00	0.54	1.63	0.54
adipose, donor4	10187-103D7	52.87	24.27	5.20	2.60	3.47	1.73	1.73	1.73	1.73	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	8.05	5.52	0.47	3.79	0.79	2.84	0.00	0.95	0.16	0.16
adrenal gland, adult, pool1	10081-102A9	0.00	0.00	0.00	3.64	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	8.67	2.67	0.40	1.73	0.00	0.93	0.13	0.00	0.13	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	33.23	5.00	6.79	0.71	1.07	0.36	0.36	2.50	0.36	0.00
amniotic membrane cells, donor1	12235-129G3	19.48	6.03	2.78	1.85	0.23	0.00	0.00	0.23	0.46	0.00
amniotic membrane cells, donor2	12236-129G4	14.54	7.10	1.35	0.34	0.34	0.00	0.34	0.00	1.01	0.68
amniotic membrane cells, donor3	12237-129G5	17.09	15.02	1.18	0.29	0.00	0.00	0.88	0.00	0.88	0.29
amygdala - adult, donor10196	10167-103B5	15.42	3.56	4.74	1.19	1.19	0.00	2.37	0.00	1.19	0.00
amygdala, adult, donor10252	10151-102I7	12.98	6.89	2.84	4.46	1.22	0.20	2.23	1.82	1.22	0.81
amygdala, newborn, donor10223	10360-105E9	14.85	5.16	7.10	3.55	1.29	0.32	1.94	2.58	0.97	1.61
anaplastic carcinoma cell line:8305C	10428-106D5	27.38	10.19	1.78	2.16	0.38	0.25	1.02	0.25	0.13	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	9.71	2.43	1.54	0.22	0.66	0.22	0.00	0.00	0.22	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	0.00	0.00	0.00	0.67	0.00	0.00	0.00	0.67	0.33	0.00
aorta, adult, pool1	10052-101G7	23.93	6.47	3.33	4.71	0.78	0.98	1.18	0.39	0.20	0.78
appendix, adult	10189-103D9	53.17	22.12	5.82	4.27	3.10	1.94	5.05	2.72	0.78	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	18.57	7.22	1.03	7.91	0.34	2.06	0.34	0.69	1.03	0.00
artery, adult	10190-103E1	12.23	1.36	9.51	4.08	1.36	0.00	4.08	0.00	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	60.12	25.35	5.22	5.65	4.35	1.74	1.01	0.29	0.58	0.43
b cell line:RPMI1788	10427-106D4	30.04	15.76	1.19	0.74	0.89	0.45	0.15	0.89	0.30	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	5.55	3.05	1.94	1.66	0.00	0.83	0.28	0.55	0.28	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	19.75	7.84	1.39	4.47	0.10	0.89	0.30	0.20	0.20	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	17.57	4.35	0.00	1.00	0.00	0.17	0.33	0.50	0.00	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	36.91	8.39	0.00	0.56	1.12	0.56	0.56	1.12	0.56	0.00
bladder, adult, pool1	10011-101C2	33.35	12.49	3.80	2.17	1.74	0.98	2.39	0.76	0.22	0.98
blood, adult, pool1	10053-101G8	62.01	17.72	2.21	2.21	4.43	4.43	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	12.85	0.00	0.86	1.71	0.00	0.86	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	36.44	8.77	4.72	12.15	2.02	0.00	4.72	3.37	1.35	4.05
brain, adult, donor1	10084-102B3	0.00	0.00	0.00	2.05	0.00	0.00	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	9.80	4.45	4.57	2.00	1.11	0.45	1.89	0.67	0.56	0.67
brain, fetal, pool1	10085-102B4	5.34	0.00	2.67	5.34	0.00	0.00	0.00	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	13.88	5.62	0.66	3.63	0.66	0.99	0.00	0.00	1.32	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	26.84	7.99	1.87	0.87	0.87	0.75	1.25	0.12	0.00	0.50
breast, adult, donor1	10080-102A8	15.15	1.89	0.63	5.05	1.89	1.26	0.63	0.63	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	5.46	2.79	0.25	0.51	0.13	0.25	0.13	0.51	0.38	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	13.91	3.71	0.31	1.55	0.93	0.00	0.00	0.00	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	24.86	7.14	2.07	0.46	0.23	0.69	0.46	0.92	0.00	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	10.65	2.18	1.69	0.73	0.00	0.73	0.00	0.48	0.73	0.00
carcinoid cell line:NCI-H1770	10703-109H1	5.17	2.35	0.00	3.76	0.00	0.94	0.00	0.47	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	16.19	4.38	0.44	2.84	0.22	0.66	0.11	0.00	0.22	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	6.65	0.95	0.32	0.95	0.63	0.63	0.63	0.32	0.00	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	6.39	2.40	0.53	5.86	0.00	0.80	0.00	1.33	2.40	0.27
caudate nucleus - adult, donor10196	10177-103C6	26.48	10.36	11.51	1.15	0.00	0.00	10.36	2.30	0.00	2.30
caudate nucleus, adult, donor10252	10164-103B2	11.04	5.02	5.02	1.84	1.51	0.84	7.36	1.00	0.50	3.35
caudate nucleus, adult, donor10258	10379-105H1	1.53	2.29	3.06	2.29	1.53	0.00	6.11	0.76	0.76	3.82
caudate nucleus, newborn, donor10223	10354-105E3	31.86	13.92	11.72	5.49	3.66	0.00	3.66	2.20	1.46	1.83
cerebellum - adult, donor10196	10173-103C2	34.96	23.31	5.83	20.39	0.00	2.91	17.48	5.83	0.00	11.65
cerebellum, adult, donor10252	10166-103B4	29.68	9.82	13.02	26.48	6.19	2.35	26.05	6.62	6.41	10.89
cerebellum, adult, pool1	10083-102B2	3.10	2.76	2.76	7.24	0.34	2.41	4.14	3.79	1.72	2.07
cerebellum, newborn, donor10223	10357-105E6	61.44	14.11	19.93	13.28	13.28	2.49	13.28	7.47	3.32	7.47
cerebral meninges, adult	10188-103D8	5.55	3.53	3.28	2.52	1.01	1.26	1.26	0.76	0.50	0.76
cerebrospinal fluid, donor2	10294-104G6	11.69	2.19	2.92	1.46	0.73	0.00	0.00	2.19	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	19.27	4.74	2.01	0.29	0.43	0.00	0.43	0.00	0.00	0.29
cervical cancer cell line:ME-180	10553-107I4	31.32	6.63	8.45	10.44	0.99	1.16	0.66	0.50	0.50	0.83
cervix, adult, pool1	10013-101C4	37.27	13.02	6.51	6.40	2.10	1.47	5.88	0.63	0.63	2.73
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	9.34	2.51	1.11	0.84	0.14	0.42	0.28	0.00	0.56	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	5.23	0.00	0.00	1.31	1.31	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	7.95	5.97	0.50	2.36	0.37	0.62	0.50	0.37	0.25	0.00
choriocarcinoma cell line:SCH	10785-110H2	0.00	0.00	0.12	3.57	0.00	1.48	0.00	0.37	0.37	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	0.00	0.24	0.00	0.71	0.00	0.24	0.00	0.00	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	15.10	3.70	2.28	3.99	0.57	0.85	0.28	0.57	1.42	0.00
chorionic membrane cells, donor2	12239-129G7	9.84	3.58	1.19	1.89	0.70	0.60	0.00	0.40	0.10	0.10
chorionic membrane cells, donor3	12240-129G8	21.43	6.59	1.65	3.30	1.10	1.65	0.55	1.10	1.10	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	5.05	1.01	0.00	0.00	0.00	0.00	0.00	2.02	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	19.02	5.57	1.54	1.54	1.73	0.38	0.19	0.19	0.00	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	16.05	4.01	1.69	2.53	0.84	0.00	0.00	0.00	0.21	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	23.63	7.96	1.28	4.37	0.00	2.31	0.00	0.26	0.26	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	16.93	6.05	1.21	4.84	1.21	0.97	0.00	0.48	0.48	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	23.21	7.94	3.46	5.90	1.43	2.04	0.41	0.20	0.20	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	75.68	24.15	5.59	9.72	0.88	0.88	0.88	1.18	1.18	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	31.01	11.21	5.99	1.30	2.87	0.78	0.26	0.26	0.00	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	13.03	4.80	0.00	1.60	0.69	0.46	0.23	0.23	0.69	0.00
clear cell carcinoma cell line:TEN	10636-108I6	34.87	11.45	1.21	2.78	0.52	0.87	0.17	1.04	0.35	0.00
colon carcinoma cell line:CACO-2	10513-107D9	22.51	8.60	1.28	4.39	0.55	1.10	0.37	0.37	0.18	0.18
colon carcinoma cell line:COLO-320	10420-106C6	52.45	20.90	7.98	4.18	1.52	0.76	0.38	0.38	0.00	0.00
colon, adult, donor1	10082-102B1	7.14	4.76	1.19	0.00	0.00	2.38	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	29.02	12.10	1.65	4.11	1.06	2.12	2.70	0.12	0.00	1.29
colon, fetal, donor1	10070-101I7	29.05	9.89	1.85	8.03	1.85	1.85	1.85	1.24	1.24	1.85
common myeloid progenitor CMP, donor1	12130-128D6	105.42	45.84	4.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	175.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	33.14	9.35	12.75	0.85	2.97	0.00	0.00	0.42	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	9.66	2.72	2.41	0.91	0.60	0.15	0.00	0.30	0.00	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	7.05	2.54	2.40	0.00	0.71	0.28	0.00	0.00	0.00	0.00
corpus callosum, adult, pool1	10042-101F6	8.84	4.75	2.87	2.21	1.33	0.33	1.44	0.00	0.11	0.66
cruciate ligament, donor2	10295-104G7	36.47	9.73	8.92	6.48	1.62	0.81	1.62	3.24	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	24.88	2.41	2.41	5.62	2.41	3.21	5.62	0.00	0.80	4.01
diencephalon, adult	10193-103E4	3.36	0.72	3.36	0.96	0.72	0.00	2.16	0.48	1.44	1.44
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	39.95	9.64	3.67	1.15	0.23	0.69	0.00	1.38	1.84	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	27.70	7.18	2.56	2.82	2.31	0.51	0.26	0.77	0.00	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	41.40	9.87	7.70	1.44	1.20	0.00	0.72	0.96	0.72	0.96
ductus deferens, adult	10196-103E7	13.95	3.49	3.49	4.98	1.50	1.50	4.49	1.99	0.00	2.49
duodenum, fetal, donor1, tech_rep1	10071-101I8	27.36	21.60	4.32	1.44	2.88	1.44	0.00	5.76	2.88	4.32
duodenum, fetal, donor1, tech_rep2	10071-101I8	58.12	23.54	5.89	12.51	0.00	2.94	6.62	1.47	5.89	5.89
dura mater, adult, donor1	10041-101F5	93.41	26.92	9.25	6.94	2.73	1.40	3.06	0.17	0.58	1.90
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	19.99	6.88	8.66	11.10	1.55	1.78	0.67	1.55	0.22	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	11.46	4.73	0.29	2.44	0.14	0.43	0.00	0.29	0.14	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	5.55	1.23	0.00	0.62	0.00	0.00	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	10.29	2.42	0.61	0.30	0.00	0.61	0.00	0.30	0.61	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	7.72	3.40	0.93	0.31	0.31	0.31	0.31	1.23	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	5.25	5.25	1.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	27.82	7.04	1.68	1.68	0.34	0.34	0.34	0.34	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	27.55	7.25	9.79	3.08	2.17	0.72	1.63	1.09	1.09	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	9.65	3.86	0.00	1.13	0.00	0.32	0.00	0.48	1.29	0.00
epidermoid carcinoma cell line:A431	10426-106D3	16.12	7.78	1.56	8.34	0.33	1.78	0.56	0.44	0.11	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	37.40	17.60	2.75	4.07	0.22	1.21	0.33	0.22	0.44	0.33
epididymis, adult	10197-103E8	25.33	5.65	5.44	2.93	2.72	1.26	6.49	1.47	1.05	1.88
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	24.31	7.10	5.14	3.73	0.89	1.06	0.89	1.24	1.06	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	11.40	3.93	1.97	2.36	0.00	0.79	0.00	0.00	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	9.70	2.10	1.05	1.05	0.26	1.05	0.13	0.92	0.66	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	19.00	5.02	3.54	1.18	0.59	0.69	0.10	0.49	0.10	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	8.96	2.58	0.67	0.90	0.22	0.56	0.00	0.11	0.56	0.11
esophagus, adult, pool1	10015-101C6	25.59	7.43	4.14	1.27	1.17	0.42	2.12	0.85	0.32	0.53
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	49.59	8.89	131.25	21.29	27.30	2.50	3.76	1.88	1.25	5.64
eye - muscle inferior rectus, donor1	10272-104E2	48.29	2.41	2.41	14.49	0.00	2.41	2.41	2.41	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	10.52	4.21	6.31	4.21	0.00	2.10	0.00	2.10	0.00	2.10
eye - muscle medial, donor2	10299-104H2	5.95	1.49	2.98	5.95	0.00	1.49	5.95	0.00	0.00	2.98
eye - muscle superior, donor2	10297-104G9	21.78	3.44	3.44	6.88	0.00	1.15	2.29	0.00	0.00	3.44
eye - vitreous humor, donor1	10268-104D7	34.98	8.74	7.29	1.46	0.00	0.00	0.00	0.00	2.91	0.00
eye, fetal, donor1	10054-101G9	15.25	7.12	20.34	3.56	1.27	1.53	8.14	1.27	0.76	4.07
fibrosarcoma cell line:HT-1080	10758-110E2	11.67	3.72	0.90	0.90	0.13	0.26	0.13	0.26	0.13	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	12.35	5.70	3.09	1.66	0.71	1.19	0.47	0.24	0.71	0.24
frontal lobe, adult, pool1	10040-101F4	7.22	4.22	2.91	6.38	1.31	0.47	3.66	0.19	0.19	1.13
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	15.31	3.60	1.20	1.80	0.00	0.60	1.20	1.50	0.90	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	24.60	8.87	2.29	2.56	0.64	1.10	0.27	0.09	0.00	0.09
gall bladder, adult	10198-103E9	18.11	4.35	1.93	2.17	0.24	1.45	2.41	0.48	0.72	1.21
gamma delta positive T cells, donor1	11937-126A2	33.28	22.01	2.68	0.00	3.76	0.00	0.54	0.54	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	35.48	26.89	6.35	1.49	2.61	0.37	0.00	1.49	0.37	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	7.18	1.90	1.06	2.96	0.42	0.21	0.21	0.42	1.27	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	21.08	6.77	2.32	0.77	0.39	0.77	0.39	0.58	0.58	0.00
gastric cancer cell line:AZ521	10549-107H9	23.94	9.51	4.59	5.25	1.97	2.95	0.49	0.33	0.16	0.33
gastric cancer cell line:GSS	10560-108A2	32.03	19.22	0.00	1.83	0.00	2.75	0.92	0.00	0.92	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	25.36	7.08	0.69	15.08	0.00	2.51	0.00	1.37	2.06	0.00
giant cell carcinoma cell line:LU65	10487-107B1	15.72	7.69	3.10	0.69	0.11	0.00	0.00	0.34	0.23	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	36.81	11.20	1.82	3.78	0.56	0.56	0.84	0.42	0.00	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	7.73	2.74	0.25	1.75	0.00	0.75	0.25	0.50	0.50	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	22.17	6.23	2.11	1.06	1.16	0.32	0.42	0.32	0.21	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	15.73	6.18	2.11	1.69	0.70	0.28	0.28	0.28	0.28	0.42
glioblastoma cell line:T98G	10485-107A8	5.19	1.55	1.10	1.66	0.66	0.77	0.33	0.22	0.11	0.00
glioma cell line:GI-1	10413-106B8	10.25	3.22	1.17	0.59	2.05	0.00	1.17	0.00	0.29	0.00
globus pallidus - adult, donor10196	10175-103C4	8.75	10.93	2.92	1.46	0.73	1.46	1.46	0.73	0.73	0.73
globus pallidus, adult, donor10252	10161-103A8	23.43	6.59	4.39	5.86	1.71	2.20	4.39	0.49	1.22	0.98
globus pallidus, adult, donor10258	10367-105F7	10.95	2.74	2.74	0.00	1.37	0.00	1.37	2.74	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	21.85	9.06	7.46	3.73	1.07	0.53	2.66	1.60	1.07	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	139.49	46.50	4.89	2.45	2.45	2.45	0.00	0.00	0.00	4.89
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	5.23	5.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	11.20	2.24	1.60	1.92	0.64	0.64	0.00	0.32	0.64	0.32
hIPS +CCl2, biol_rep1	14383-156B9	37.19	27.09	10.10	4.13	2.30	0.92	0.00	1.84	0.92	0.00
hIPS +CCl2, biol_rep2	14384-156C1	40.70	21.03	15.55	3.20	1.83	0.46	0.91	1.37	1.83	0.91
hIPS +CCl2, biol_rep3	14385-156C2	21.26	19.97	9.66	2.58	4.51	0.64	1.29	1.93	0.64	0.64
hIPS, biol_rep1	14380-156B6	27.31	18.68	23.00	8.62	0.00	0.00	2.87	0.00	0.00	4.31
hIPS, biol_rep2	14381-156B7	19.89	19.20	14.40	3.43	1.37	0.69	1.37	0.69	0.00	2.06
hIPS, biol_rep3	14382-156B8	9.93	1.10	11.03	1.10	1.10	0.00	6.62	2.21	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	19.25	6.32	4.60	0.00	1.15	0.00	0.29	0.29	0.57	0.57
heart - mitral valve, adult	10205-103F7	39.46	9.27	14.65	9.87	4.48	2.39	6.58	0.90	0.90	4.48
heart - pulmonic valve, adult	10206-103F8	12.55	1.83	3.14	5.75	1.31	0.52	5.75	2.35	1.05	1.83
heart - tricuspid valve, adult	10207-103F9	29.14	3.33	4.16	9.99	1.67	2.50	1.67	0.83	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	9.18	2.86	1.43	1.02	0.61	1.22	0.20	0.82	1.02	0.00
heart, adult, diseased, donor1	10051-101G6	6.81	1.70	0.85	0.00	0.00	0.43	0.00	0.00	0.43	0.00
heart, adult, pool1	10016-101C7	8.51	1.84	0.92	1.61	0.69	0.23	0.92	0.23	0.23	0.69
heart, fetal, pool1	10046-101G1	48.26	16.22	8.11	11.09	3.39	2.67	3.49	0.41	0.31	0.72
hepatic mesenchymal tumor cell line:LI90	10778-110G4	4.01	0.31	0.93	1.85	0.31	0.93	0.00	0.31	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	10.70	7.14	3.57	2.38	0.00	4.76	0.00	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	17.24	4.75	1.55	2.65	0.11	0.88	1.44	0.55	1.10	0.33
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	15.17	2.79	1.82	3.16	0.49	0.85	1.09	0.36	0.97	0.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	19.30	7.17	1.92	2.12	0.61	0.91	1.52	0.61	0.91	0.30
hepatoma cell line:Li-7	10484-107A7	22.02	6.12	3.78	2.11	0.67	0.56	0.44	0.78	0.33	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	16.68	4.32	0.90	1.31	0.80	0.70	0.20	0.20	0.30	0.30
hippocampus - adult, donor10196	10169-103B7	12.30	7.57	0.95	3.79	1.89	2.84	5.68	1.89	0.95	0.95
hippocampus, adult, donor10252	10153-102I9	18.16	6.53	4.69	4.08	2.45	0.61	4.69	1.43	1.22	3.06
hippocampus, adult, donor10258	10374-105G5	2.49	1.49	0.50	7.97	1.00	1.00	1.00	0.00	0.50	0.50
hippocampus, newborn, donor10223	10363-105F3	3.88	2.82	3.52	2.82	0.35	0.35	1.41	0.70	0.70	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	137.94	53.71	48.83	6.10	9.16	1.83	1.22	4.88	3.05	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	60.87	30.63	18.06	3.93	2.55	0.79	1.57	1.96	1.77	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	65.25	41.38	20.82	5.08	3.81	0.76	0.25	4.32	3.30	1.02
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	2.82	2.82	7.33	2.82	2.26	0.56	0.00	1.13	0.56	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	4.13	1.81	20.66	3.61	3.36	1.29	0.00	3.10	6.46	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	3.80	3.42	8.35	3.42	3.42	0.76	0.00	1.90	0.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	6.42	5.26	11.39	5.55	3.50	0.88	0.29	0.58	0.88	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	7.76	8.40	9.69	9.05	2.80	0.86	0.22	1.51	1.29	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	5.84	4.59	9.59	2.92	1.25	1.67	0.00	1.25	0.42	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	7.81	4.74	4.26	2.84	3.55	0.95	0.24	0.71	0.24	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	10.29	4.18	7.07	3.05	3.05	0.48	0.16	1.45	1.13	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	10.77	0.67	1.35	1.35	5.39	0.00	0.00	1.35	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	79.02	41.47	14.55	2.97	2.82	0.63	0.78	2.82	2.19	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	97.77	39.79	28.99	2.95	7.37	0.98	1.97	2.95	8.84	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	150.99	65.46	37.53	6.11	6.11	1.75	5.24	9.60	3.49	4.36
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	3.44	3.25	10.31	2.86	4.01	0.76	0.00	2.29	1.72	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	3.92	2.62	9.16	2.62	1.74	2.18	0.00	0.87	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	8.50	6.00	10.99	3.50	2.00	2.00	0.00	1.50	1.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	13.56	11.12	7.54	6.59	1.70	1.51	0.00	1.88	0.57	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	12.73	8.18	6.82	4.55	0.45	0.91	0.00	0.45	1.82	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	9.71	10.96	6.58	3.76	1.57	0.94	0.31	0.63	0.63	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	16.98	6.70	6.53	2.94	2.78	0.65	0.00	1.31	1.31	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	16.84	5.81	5.52	1.16	2.90	0.29	0.00	0.87	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	11.66	7.77	6.88	2.99	1.49	0.60	0.00	0.60	0.60	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	57.46	26.42	16.63	4.99	2.59	0.37	1.66	1.66	2.59	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	56.20	21.11	15.12	4.56	2.85	0.29	0.86	3.14	2.00	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	88.20	42.87	32.26	4.49	5.72	0.41	2.04	4.08	3.27	4.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	8.80	5.28	14.08	4.22	2.82	0.70	0.00	1.06	1.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	9.19	4.43	6.33	1.27	1.90	0.95	0.63	2.22	0.32	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	3.03	3.33	7.57	3.03	2.72	0.30	0.00	0.91	0.61	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	10.86	7.24	6.21	5.17	2.07	1.55	0.00	2.07	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	10.63	10.63	7.97	1.33	1.99	1.99	0.66	0.66	0.66	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	13.08	7.18	6.67	3.08	1.54	0.77	0.26	1.03	0.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	13.04	4.35	5.88	2.05	1.79	0.26	0.26	1.53	1.79	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	12.87	9.84	6.82	4.54	3.03	1.51	0.00	0.76	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	16.13	6.39	6.72	1.01	2.35	0.00	0.00	1.34	0.67	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	50.47	26.32	15.21	5.07	3.62	0.00	0.48	1.45	1.93	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	71.31	42.34	28.97	4.01	4.01	0.89	2.23	4.01	1.34	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	55.12	25.37	17.56	5.85	2.93	1.46	0.49	3.90	1.95	1.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	4.28	2.44	9.47	3.67	3.67	0.92	0.00	0.31	0.61	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	45.55	16.27	97.60	13.01	19.52	6.51	0.00	0.00	9.76	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	5.30	3.31	19.86	3.64	5.30	1.32	0.00	0.66	1.32	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	9.30	3.28	8.76	6.02	3.28	0.00	0.55	0.55	1.09	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	5.79	5.79	7.60	2.17	2.17	1.81	0.00	0.72	0.72	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	4.98	3.91	11.74	3.91	3.91	0.71	0.00	0.71	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	9.55	7.16	3.58	0.00	2.39	0.00	0.00	1.19	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	10.97	9.48	6.36	4.88	4.33	0.68	0.14	0.14	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	7.00	3.23	4.58	3.77	1.89	0.27	0.00	1.08	1.62	0.00
immature langerhans cells, donor1	11904-125F5	160.30	54.97	25.18	1.70	7.75	0.24	0.97	0.73	0.73	0.48
immature langerhans cells, donor2	11905-125F6	131.49	41.19	14.26	3.17	5.54	0.00	1.58	2.38	1.58	1.58
insula, adult, pool1	10039-101F3	3.97	2.46	1.23	5.49	0.95	1.23	1.32	0.00	0.09	0.28
keratoacanthoma cell line:HKA-1	10791-110H8	3.25	2.60	0.33	0.98	0.00	0.65	0.33	0.33	0.00	0.00
kidney, adult, pool1	10017-101C8	26.63	7.51	1.40	2.20	1.50	0.90	1.10	0.40	0.40	0.20
kidney, fetal, pool1	10045-101F9	21.86	9.69	0.99	6.58	0.78	2.33	0.85	0.14	0.00	0.50
large cell lung carcinoma cell line:IA-LM	10509-107D5	51.13	19.17	2.70	3.12	0.71	0.57	0.43	0.57	0.43	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	5.39	1.66	2.49	0.28	1.24	0.28	0.00	0.41	0.69	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	16.70	8.62	2.20	2.57	0.55	2.02	0.18	0.37	0.00	0.55
left atrium, adult, donor1	10079-102A7	17.44	5.99	3.27	0.00	1.09	1.09	0.54	0.54	1.09	1.09
left ventricle, adult, donor1	10078-102A6	6.07	1.52	2.02	0.51	0.00	0.00	0.00	0.51	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	10.94	1.92	1.37	2.19	0.55	1.09	0.55	0.82	0.55	0.00
leiomyoma cell line:10964C	10569-108B2	5.75	0.36	0.72	0.00	0.00	0.00	0.72	0.00	0.36	0.00
leiomyoma cell line:15242A	10570-108B3	2.17	0.54	1.09	0.00	0.54	0.00	0.54	0.00	0.54	0.00
leiomyoma cell line:15425	10571-108B4	7.53	0.97	2.67	0.24	0.73	0.00	0.24	0.24	0.00	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	0.00	0.00	6.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	42.87	6.27	5.23	2.09	0.00	0.00	0.00	0.00	1.05	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	14.99	3.19	1.77	0.83	0.35	0.24	0.12	0.24	0.24	0.47
liposarcoma cell line:KMLS-1	10782-110G8	10.00	3.12	1.41	1.09	0.62	0.62	0.31	0.78	0.47	0.00
liposarcoma cell line:SW 872	10726-110A6	3.78	1.58	0.12	1.58	0.24	0.97	0.12	0.12	0.00	0.73
liver, adult, pool1	10018-101C9	25.77	6.97	0.97	1.46	0.32	0.32	1.62	0.16	0.32	0.00
liver, fetal, pool1	10086-102B5	12.23	5.64	0.94	0.00	0.94	0.94	1.88	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	18.23	6.71	5.40	4.96	0.87	1.31	3.06	2.33	0.29	1.02
locus coeruleus, adult, donor10252	10165-103B3	17.72	5.72	4.61	3.51	1.85	0.74	4.24	1.11	0.55	1.85
locus coeruleus, adult, donor10258	10375-105G6	4.80	2.54	3.67	2.82	1.69	0.28	1.97	1.97	0.85	1.13
locus coeruleus, newborn, donor10223	10362-105F2	36.59	19.77	21.45	2.52	5.05	0.00	7.57	0.84	2.10	4.21
lung adenocarcinoma cell line:A549	10499-107C4	14.81	4.29	0.55	0.55	0.28	0.28	0.14	0.28	0.00	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	17.24	6.20	0.69	1.38	2.07	0.00	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	26.23	5.67	0.66	4.22	0.13	1.32	0.00	0.26	0.66	0.00
lung, adult, pool1	10019-101D1	59.06	27.52	5.32	4.25	1.18	2.24	1.77	0.24	0.47	1.30
lung, fetal, donor1	10068-101I5	194.65	57.65	23.40	38.53	9.99	7.42	20.26	1.14	0.00	7.71
lung, right lower lobe, adult, donor1	10075-102A3	20.16	6.42	4.12	5.50	0.00	1.83	3.67	4.58	2.29	0.92
lymph node, adult, donor1	10077-102A5	25.09	14.67	1.89	0.47	0.47	0.47	0.95	0.95	2.37	0.00
lymphangiectasia cell line:DS-1	10727-110A7	11.40	3.07	0.66	1.53	0.22	0.88	0.00	0.44	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	91.01	20.68	7.24	3.77	2.87	1.36	1.66	0.91	0.15	1.96
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	52.67	10.19	4.25	0.85	5.10	0.00	0.85	0.00	0.00	0.85
mature adipocyte, donor1	12231-129F8	32.86	9.77	5.77	5.77	0.44	0.89	3.55	0.00	0.00	0.44
mature adipocyte, donor2	12232-129F9	92.77	24.90	10.38	6.02	0.83	0.42	5.40	0.42	0.62	0.83
mature adipocyte, donor3	12233-129G1	53.58	15.17	9.72	2.61	1.19	0.71	2.84	0.24	0.24	1.66
mature adipocyte, donor4	12234-129G2	63.44	13.69	8.69	3.95	1.32	0.00	3.69	0.26	0.26	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	70.76	20.73	5.00	1.67	5.48	0.71	0.24	0.48	0.71	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	10.15	3.38	2.26	3.38	0.00	2.26	2.26	1.13	0.00	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	16.74	4.05	3.49	5.89	1.84	1.66	4.60	3.31	2.21	2.21
medial frontal gyrus, adult, donor10258	10368-105F8	2.22	2.22	1.27	1.59	0.32	1.27	0.95	0.95	0.95	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	56.30	14.50	19.62	10.24	4.69	0.85	3.41	2.99	2.13	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	15.19	3.71	3.04	5.57	1.01	1.01	2.70	6.41	8.61	1.35
medial temporal gyrus, adult, donor10252	10156-103A3	13.37	3.61	4.24	7.85	1.27	1.70	4.46	3.40	2.97	1.27
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	0.00	3.85	0.00	7.71	1.93	0.00	3.85	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	0.00	0.00	14.35	14.35	14.35	0.00	0.00	0.00	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	20.82	6.10	5.74	6.46	0.72	1.08	1.44	0.36	0.72	0.36
medulla oblongata - adult, donor10196	10174-103C3	22.71	11.68	3.24	2.60	1.95	0.00	0.65	1.95	0.00	1.30
medulla oblongata, adult, donor10252	10155-103A2	22.76	7.89	3.87	3.87	2.17	1.39	6.19	0.62	1.24	1.70
medulla oblongata, adult, pool1	10038-101F2	9.63	3.43	2.61	2.94	0.90	0.73	2.45	0.00	0.24	0.73
medulla oblongata, newborn, donor10223	10361-105F1	18.40	6.25	4.86	2.43	1.74	0.00	2.08	1.04	0.35	0.69
medulloblastoma cell line:D283 Med	10838-111E1	31.44	5.76	24.13	14.17	2.66	1.55	0.66	2.21	1.11	0.22
medulloblastoma cell line:ONS-76	10759-110E3	4.16	1.10	0.12	1.22	0.00	0.37	0.00	0.12	0.00	0.00
melanoma cell line:COLO 679	10514-107E1	10.06	1.15	3.45	1.15	0.86	0.00	0.14	0.29	0.14	0.14
melanoma cell line:G-361	10465-106H6	4.07	1.09	1.63	0.27	0.00	0.00	0.00	0.54	0.00	0.27
meningioma cell line:HKBMM	10691-109F7	12.48	2.53	0.90	0.90	0.18	0.18	0.18	0.72	0.72	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	24.67	7.05	1.76	0.88	0.00	0.88	0.00	4.41	2.64	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	7.26	1.30	0.26	1.56	0.00	0.26	0.00	0.26	0.00	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	12.43	3.22	3.38	1.99	0.77	1.07	0.15	0.46	0.15	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	16.18	4.36	2.00	3.09	1.64	1.09	0.00	0.55	0.55	0.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	19.46	4.97	1.66	1.66	0.83	0.83	0.00	0.41	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	13.20	4.07	2.67	0.42	0.84	0.00	0.28	0.00	0.00	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	10.59	3.27	1.35	1.16	0.19	0.19	0.00	0.39	0.19	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	10.41	2.08	2.08	0.00	0.00	0.69	0.00	0.69	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	22.48	6.52	2.06	1.54	1.03	0.34	0.00	0.00	0.34	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	10.47	2.99	3.11	0.92	0.35	1.15	0.23	0.23	0.12	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	9.55	2.79	4.11	1.86	0.53	0.40	0.00	0.13	0.40	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	15.26	5.94	4.32	1.22	0.95	0.54	0.14	0.54	0.41	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	20.06	6.40	3.27	0.85	0.43	0.71	0.57	0.14	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	18.11	7.25	5.27	0.99	0.66	0.00	0.00	0.33	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	21.17	6.92	3.32	1.94	1.11	0.28	0.42	0.14	0.28	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	12.92	3.49	2.44	0.70	0.35	0.70	0.35	1.05	0.00	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	14.70	4.08	2.25	1.43	0.41	0.41	0.20	0.00	0.41	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	14.38	4.31	4.67	1.80	0.36	0.72	0.36	0.36	0.72	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	11.79	6.52	2.38	0.21	0.72	0.41	0.10	0.21	0.00	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	7.98	2.51	3.42	1.37	0.23	0.46	0.00	0.68	0.46	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	28.53	10.49	6.29	1.26	1.26	0.42	0.84	0.42	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	20.62	8.52	3.89	2.09	0.15	0.75	0.30	0.15	0.15	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	15.06	5.95	2.28	1.58	0.53	0.35	0.09	0.18	0.35	0.35
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	19.88	6.26	8.47	1.84	0.74	0.74	0.74	0.74	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	12.88	6.30	3.43	1.14	0.57	0.29	0.57	0.86	0.57	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	20.21	5.89	6.74	0.84	0.84	0.42	0.42	0.84	2.11	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	2.74	0.46	0.00	1.37	0.00	1.37	0.00	0.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	4.09	0.00	0.51	3.07	0.00	0.00	0.00	0.26	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	3.66	1.05	0.26	1.57	0.26	0.00	0.26	0.26	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	2.16	0.62	0.31	0.62	0.00	0.00	0.00	0.00	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	3.29	0.47	0.71	0.94	0.00	0.24	0.00	0.00	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	4.06	1.69	0.00	0.68	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	3.93	0.00	1.18	1.57	0.39	0.39	0.00	0.39	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	2.78	0.46	0.00	0.00	0.00	0.00	0.00	0.46	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	3.75	1.15	0.87	1.44	0.58	0.58	0.29	0.29	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	3.12	0.67	0.22	2.90	0.00	0.22	0.00	0.00	0.00	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	2.40	1.44	0.48	0.72	0.00	0.00	0.00	0.00	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	2.93	0.00	0.00	1.47	0.73	1.47	0.73	0.00	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	2.69	0.34	0.67	1.68	0.00	0.34	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	3.68	0.82	0.00	0.82	0.82	0.00	0.00	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	3.87	0.43	0.43	0.43	0.00	0.00	1.29	0.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	2.73	2.73	0.00	2.73	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	0.00	0.00	5.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	2.27	0.32	0.65	1.30	0.00	0.65	0.00	0.00	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	5.82	1.45	0.00	0.00	0.00	0.00	1.45	2.91	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	1.07	0.53	0.00	1.60	0.00	0.00	0.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	3.27	0.00	0.00	0.82	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	1.94	1.17	0.78	3.11	0.39	0.00	0.39	0.00	0.78	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	4.20	0.00	2.10	2.10	2.10	0.00	0.00	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	0.99	0.00	0.00	2.98	0.00	0.00	0.00	0.99	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	0.00	0.00	4.77	0.00	4.77	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	1.78	0.00	1.78	1.78	0.59	0.59	0.00	0.59	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	0.00	0.00	0.00	3.66	0.00	1.22	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	3.17	0.63	0.00	1.90	0.00	0.63	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	2.76	0.34	0.34	0.69	0.00	0.00	0.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	4.30	0.00	0.00	0.00	2.15	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	0.00	0.00	0.00	0.00	3.99	0.00	0.00	0.00	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	2.04	0.81	0.81	1.22	0.41	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	3.18	0.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	1.18	1.77	0.00	1.77	0.00	0.00	0.59	1.18	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	4.05	0.62	0.00	1.56	0.00	0.31	0.00	0.00	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	4.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	4.73	2.37	0.00	0.00	1.18	0.00	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	2.57	2.57	0.00	0.00	0.00	0.00	2.57	0.00	5.14	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	4.13	0.69	0.00	1.38	0.69	0.00	0.69	0.00	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	0.49	0.00	1.48	1.48	0.00	0.49	0.99	0.00	1.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	0.00	0.00	0.00	1.12	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	1.27	0.64	0.00	0.00	0.00	0.00	0.00	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	0.40	0.00	0.00	0.40	0.00	0.00	0.00	0.00	0.00	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	0.00	0.00	0.00	1.27	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	1.21	0.00	0.00	0.00	0.00	0.61	0.61	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	0.00	0.00	0.00	0.00	0.00	0.00	4.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	0.00	0.00	0.00	0.82	0.00	0.00	0.82	0.00	1.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	3.57	0.79	0.60	0.60	0.40	0.00	1.79	0.00	0.40	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	2.60	0.65	0.65	1.30	0.00	0.00	0.65	0.00	0.97	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	2.04	3.06	1.02	1.02	0.00	0.00	0.00	0.00	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	6.96	4.64	1.55	2.32	2.32	1.55	1.55	0.00	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	9.69	1.18	0.47	2.60	0.24	1.89	0.00	0.00	0.24	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	42.86	9.96	4.87	5.10	0.70	1.16	1.39	0.46	0.23	1.62
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	17.09	4.27	0.00	4.27	0.00	0.00	0.00	0.00	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	26.41	5.55	1.44	2.98	1.34	0.21	0.31	1.75	0.41	0.21
mesothelioma cell line:Mero-25	10850-111F4	6.35	1.59	2.72	1.36	0.68	0.23	0.00	0.00	0.23	0.45
mesothelioma cell line:Mero-41	10851-111F5	2.93	0.98	0.24	0.73	0.00	0.49	0.00	0.24	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	8.86	2.88	1.33	0.66	0.89	0.44	0.22	0.66	0.22	0.00
mesothelioma cell line:Mero-82	10853-111F7	12.88	2.10	2.10	1.58	0.53	0.00	0.53	0.00	0.53	0.00
mesothelioma cell line:Mero-83	10854-111F8	13.11	2.72	2.21	2.38	1.19	0.51	0.00	0.17	0.00	0.00
mesothelioma cell line:Mero-84	10855-111F9	4.04	2.53	0.76	1.52	0.25	0.76	0.00	0.00	0.25	0.00
mesothelioma cell line:Mero-95	10856-111G1	6.00	1.66	0.83	0.83	0.41	0.41	0.41	0.21	0.21	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	11.26	2.48	1.66	1.82	0.00	0.33	0.50	0.17	0.66	0.00
mesothelioma cell line:NCI-H226	10846-111E9	18.28	1.99	1.81	2.35	0.54	0.18	0.18	0.36	0.18	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	23.74	3.93	2.56	1.20	0.17	0.51	0.34	0.51	1.02	0.00
mesothelioma cell line:NCI-H28	10845-111E8	24.68	5.85	1.02	1.02	0.76	0.00	0.76	1.02	0.51	0.00
mesothelioma cell line:No36	10857-111G2	8.48	3.91	1.96	0.98	0.33	0.33	0.00	0.33	0.98	0.00
mesothelioma cell line:ONE58	10858-111G3	14.90	3.79	2.17	1.90	0.81	0.00	0.27	0.00	0.27	0.00
migratory langerhans cells, donor1	11901-125F2	26.49	14.01	0.77	1.15	0.96	0.38	0.38	0.77	0.77	0.19
migratory langerhans cells, donor2	11902-125F3	19.17	7.69	0.73	0.98	1.22	0.85	0.00	0.24	0.24	0.37
migratory langerhans cells, donor3	11903-125F4	22.79	8.62	1.62	0.36	0.36	0.36	0.00	0.18	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	3.92	0.98	0.65	1.31	0.00	0.00	0.33	0.33	0.65	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	10.17	2.97	2.12	2.76	0.21	0.64	0.21	1.27	0.85	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	20.50	6.91	0.92	1.38	0.23	0.69	0.00	0.69	0.00	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	16.75	5.14	2.66	0.76	0.76	0.38	0.38	0.19	0.00	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	30.49	8.69	1.11	2.77	0.92	0.74	0.37	0.55	0.55	0.18
myeloma cell line:PCM6	10474-106I6	14.43	3.16	0.20	0.20	0.40	0.00	0.40	0.20	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	5.07	1.01	0.51	1.52	0.00	0.51	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	16.28	4.71	2.94	1.57	0.39	0.39	0.20	0.20	0.39	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	17.94	8.58	1.89	0.45	0.45	0.11	0.00	0.33	0.11	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	31.25	8.75	2.87	0.74	0.37	0.07	0.07	0.15	0.15	0.07
nasal epithelial cells, donor2	12227-129F4	27.60	7.73	3.31	1.10	3.31	0.00	0.55	0.00	1.10	0.00
neuroblastoma cell line:CHP-134	10508-107D4	19.56	10.35	2.30	1.15	3.91	0.00	0.92	0.69	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	11.41	5.05	1.68	1.50	0.75	0.00	0.37	0.00	0.19	0.56
neuroblastoma cell line:NBsusSR	10607-108F4	13.92	2.32	5.69	3.37	1.05	0.21	0.84	0.84	0.21	0.00
neuroblastoma cell line:NH-12	10555-107I6	24.78	5.78	3.91	9.50	4.10	2.80	0.93	1.49	1.30	0.56
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	0.71	1.19	0.47	0.00	0.00	0.24	0.00	1.19	0.71	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	21.06	2.69	6.49	2.69	1.43	0.00	0.16	0.95	0.63	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	3.82	0.81	1.01	0.20	1.01	0.00	0.20	0.20	0.20	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	2.54	0.00	0.64	0.64	0.64	0.00	0.00	0.64	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	5.06	0.80	0.80	1.86	0.00	0.00	0.00	0.27	0.27	0.27
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	172.65	53.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	66.29	75.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	74.75	22.49	4.74	25.03	9.13	8.79	0.00	1.18	1.35	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	10.41	4.00	1.60	0.80	0.80	0.00	0.00	0.00	0.00	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	11.54	1.60	0.32	0.64	1.60	0.32	0.32	0.64	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	4.73	3.15	0.79	0.79	0.26	0.00	0.26	0.26	0.53	0.00
nucleus accumbens, adult, pool1	10037-101F1	5.16	2.34	1.50	3.19	1.03	0.84	2.34	0.09	0.09	0.94
occipital cortex - adult, donor10196	10172-103C1	22.66	2.06	4.12	12.36	0.00	2.06	2.06	0.00	2.06	2.06
occipital cortex, adult, donor10252	10163-103B1	19.32	5.90	2.95	5.10	2.42	2.15	6.17	1.07	1.88	2.42
occipital cortex, newborn, donor10223	10355-105E4	22.93	5.10	6.55	8.37	1.09	0.00	2.18	1.09	2.18	3.28
occipital lobe, adult, donor1	10076-102A4	5.25	1.31	0.79	3.94	0.52	1.57	1.31	1.84	0.52	1.84
occipital lobe, fetal, donor1	10073-102A1	16.73	3.00	9.01	12.01	4.72	3.86	1.72	11.59	0.43	1.29
occipital pole, adult, pool1	10036-101E9	2.13	0.71	0.08	2.44	0.08	1.02	0.71	0.00	0.08	0.24
olfactory region, adult	10195-103E6	4.59	2.67	1.34	3.63	0.19	1.15	3.06	1.34	0.96	1.34
optic nerve, donor1	10277-104E7	6.00	0.00	0.00	4.00	0.00	0.00	6.00	2.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	34.74	12.87	2.28	2.05	0.57	0.68	0.11	0.23	0.23	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	12.09	6.05	0.41	4.95	0.00	1.37	0.14	0.27	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	16.42	5.42	1.86	1.86	0.00	0.51	0.17	0.68	2.37	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	15.25	4.62	2.43	3.58	0.46	0.81	0.00	0.46	0.35	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	3.82	2.94	0.88	2.65	0.00	1.47	0.00	0.59	0.29	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	23.36	4.67	6.54	0.93	4.67	2.80	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	2.97	0.85	0.42	2.12	0.85	0.21	1.06	0.21	0.21	0.00
ovary, adult, pool1	10020-101D2	20.88	7.51	4.02	3.14	1.31	0.52	5.24	0.70	0.17	1.92
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	6.78	2.38	1.47	1.10	0.73	0.73	0.18	0.18	0.73	0.00
pancreas, adult, donor1	10049-101G4	7.53	0.94	0.00	1.88	0.00	0.00	1.88	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	0.00	0.00	0.00	1.12	0.00	0.28	0.00	0.28	0.28	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	16.18	3.41	1.36	2.56	0.17	0.17	0.00	1.36	2.38	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	54.31	22.19	4.31	7.12	0.99	2.32	0.00	0.50	0.33	0.50
paracentral gyrus, adult, pool1	10035-101E8	3.94	2.38	0.82	5.95	0.46	1.10	1.37	0.09	0.00	1.10
parietal cortex, adult, donor10258	10373-105G4	4.40	0.73	4.40	4.40	2.20	0.00	1.47	0.00	0.73	2.20
parietal lobe - adult, donor10196	10171-103B9	10.35	1.88	1.88	4.70	0.94	0.94	1.88	0.94	1.88	0.00
parietal lobe, adult, donor10252	10157-103A4	14.82	6.27	1.43	10.55	1.43	2.85	3.99	2.00	1.71	2.00
parietal lobe, adult, pool1	10034-101E7	3.44	1.76	0.79	4.49	0.18	0.97	2.20	0.18	0.18	0.44
parietal lobe, fetal, donor1	10072-101I9	22.31	7.76	15.52	32.97	5.82	5.82	0.00	20.37	1.94	1.94
parietal lobe, newborn, donor10223	10356-105E5	31.03	6.73	8.22	7.10	1.50	1.12	1.87	1.87	0.75	2.62
parotid gland, adult	10199-103F1	9.25	3.08	1.23	1.85	1.85	0.00	1.85	0.00	0.00	0.00
penis, adult	10200-103F2	19.34	5.91	4.83	3.76	2.15	3.22	4.30	0.54	1.07	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	23.61	2.97	0.19	0.93	0.37	0.56	0.00	0.74	0.19	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	9.47	2.19	0.44	2.48	0.29	1.31	0.58	0.29	0.58	0.00
pineal gland - adult, donor10196	10179-103C8	14.84	9.03	40.64	5.81	5.81	2.58	1.94	2.58	0.00	3.23
pineal gland, adult, donor10252	10160-103A7	25.47	15.99	114.30	13.62	7.11	1.18	7.11	4.15	0.59	13.62
pineal gland, adult, donor10258	10377-105G8	12.54	8.78	29.47	2.51	0.63	1.88	3.76	2.51	0.00	1.25
pituitary gland - adult, donor10196	10180-103C9	19.22	17.20	3.04	7.08	2.02	2.02	1.01	0.00	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	36.48	22.41	5.73	11.99	5.73	4.69	13.55	0.00	1.04	3.65
pituitary gland, adult, donor10258	10378-105G9	8.51	11.92	0.85	3.40	0.85	0.85	0.85	0.85	1.70	3.40
placenta, adult, pool1	10021-101D3	10.32	3.55	1.08	4.30	0.65	1.40	0.32	0.32	0.00	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	36.15	13.24	6.09	1.46	1.32	0.13	0.26	1.06	0.53	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	22.10	5.45	2.18	1.56	0.31	0.31	0.16	0.16	0.16	0.31
pons, adult, pool1	10033-101E6	13.94	7.83	4.73	7.06	2.07	1.12	4.13	0.34	0.17	1.64
postcentral gyrus, adult, pool1	10032-101E5	3.05	1.31	0.44	3.31	0.17	0.26	0.96	0.00	0.09	0.44
promyelocytes/myelocytes PMC, donor1	12132-128D8	6.27	2.09	0.00	2.09	0.00	2.09	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	55.08	22.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	11.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	22.14	5.10	4.22	2.18	1.46	0.44	0.44	0.58	0.00	0.29
prostate cancer cell line:PC-3	10439-106E7	80.59	17.79	5.99	17.24	0.91	2.72	0.73	2.90	1.45	0.73
prostate, adult, pool1	10022-101D4	20.41	6.26	3.54	4.26	1.45	1.90	3.08	0.18	0.09	0.63
putamen, adult, donor10196	10176-103C5	13.22	4.25	3.54	3.07	1.89	0.94	7.32	1.89	2.60	2.36
putamen, adult, donor10252	10152-102I8	9.80	1.96	9.80	17.65	1.96	0.00	9.80	1.96	0.00	3.92
putamen, adult, donor10258, tech_rep1	10372-105G3	9.84	9.84	6.56	3.28	3.28	1.09	6.56	0.00	0.00	8.74
putamen, adult, donor10258, tech_rep2	10372-105G3	5.32	1.69	2.42	1.21	0.24	0.48	2.66	0.24	0.00	2.66
putamen, newborn, donor10223	10365-105F5	74.97	26.99	33.73	3.00	4.50	0.00	4.50	2.25	3.75	3.00
rectal cancer cell line:TT1TKB	10469-106I1	39.28	17.75	4.36	6.11	2.33	2.04	0.00	0.87	0.29	0.87
rectum, fetal, donor1	10067-101I4	16.69	2.78	5.56	9.74	5.56	9.74	1.39	2.78	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	10.60	2.97	1.27	1.06	0.21	0.21	0.21	0.00	0.21	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	16.57	9.53	2.90	1.24	0.41	2.07	1.24	0.41	2.07	0.00
retina, adult, pool1	10030-101E3	16.10	9.05	10.14	5.07	0.80	1.19	5.57	0.20	0.00	2.48
retinoblastoma cell line:Y79	10475-106I7	13.25	3.38	6.75	2.60	1.04	1.56	0.00	0.52	1.04	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	4.92	1.11	1.48	7.25	0.25	1.60	0.37	0.49	0.00	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	46.40	7.31	4.22	7.31	2.53	1.97	0.28	0.56	0.00	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	2.27	0.76	0.00	3.03	0.00	0.76	1.52	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	7.77	1.62	2.43	0.65	0.32	0.81	0.00	0.16	0.81	0.00
salivary acinar cells, donor2	11772-123I8	7.99	1.24	0.55	1.24	0.14	0.41	0.14	0.00	0.28	0.00
salivary acinar cells, donor3	11773-123I9	3.97	3.31	0.00	2.65	0.00	2.65	0.00	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	10.30	6.29	0.57	6.86	0.00	1.14	2.29	0.00	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	29.34	13.49	7.08	0.59	0.42	0.00	0.17	0.59	0.59	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	24.80	10.81	5.64	0.82	0.47	0.24	0.35	1.29	0.24	0.12
seminal vesicle, adult	10201-103F3	17.99	4.23	2.65	11.11	0.53	0.53	6.35	2.65	1.59	2.65
serous adenocarcinoma cell line:JHOS-2	10639-108I9	30.37	7.53	1.70	5.34	0.49	0.73	0.49	1.21	0.97	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	25.16	4.78	7.05	1.76	1.26	0.75	0.25	0.50	0.00	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	18.06	6.02	2.01	0.00	2.01	0.00	0.00	0.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	17.19	3.76	0.54	2.55	0.00	0.94	0.00	0.54	0.94	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	13.48	2.76	1.88	0.66	0.22	0.22	0.00	0.22	0.22	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	35.09	8.39	0.65	0.90	1.16	0.26	0.26	0.39	0.13	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	7.09	2.84	2.84	4.26	0.00	1.42	0.71	0.71	2.13	0.71
skeletal muscle, adult, pool1	10023-101D5	13.67	1.68	5.64	1.80	2.04	0.72	1.68	0.60	0.24	0.24
skeletal muscle, fetal, donor1	10066-101I3	11.06	4.02	2.01	2.01	2.01	1.01	1.01	1.01	0.00	3.02
skin, adult, donor1	10074-102A2	20.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	46.08	11.36	5.05	5.05	1.89	3.16	3.79	3.79	3.16	2.52
small cell cervical cancer cell line:HCSC-1	10800-110I8	2.67	2.33	0.00	1.33	0.00	0.33	0.00	0.00	0.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	64.62	12.61	4.41	8.83	1.58	0.63	2.21	3.15	4.10	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	4.82	2.31	3.66	7.13	0.77	3.28	0.00	1.54	0.77	0.77
small cell lung carcinoma cell line:LK-2	10541-107H1	27.86	11.70	2.14	1.15	1.98	0.82	0.16	0.16	0.16	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	18.98	8.53	7.56	3.54	0.64	0.80	0.00	0.64	0.97	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	11.77	1.31	1.53	3.05	0.22	1.53	1.09	0.22	0.00	0.00
small intestine, adult, pool1	10024-101D6	43.24	14.93	3.34	7.52	1.07	2.39	4.18	0.72	0.24	2.03
small intestine, fetal, donor1	10064-101I1	29.97	9.83	1.23	9.09	0.98	1.47	1.47	1.72	0.98	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	21.03	6.15	0.51	1.03	0.00	0.00	0.00	1.54	2.05	0.00
smooth muscle, adult, pool1	10048-101G3	12.15	3.36	3.88	2.33	2.07	2.33	1.29	1.03	1.55	0.52
somatostatinoma cell line:QGP-1	10781-110G7	17.15	4.02	0.80	1.61	0.00	0.27	0.27	0.80	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	26.15	11.47	5.05	4.36	0.46	1.61	3.67	2.29	2.06	1.38
spinal cord, adult, donor10252	10159-103A6	36.27	18.14	3.15	3.55	1.18	0.39	4.34	1.58	0.39	1.58
spinal cord, adult, donor10258	10369-105F9	6.92	6.92	4.15	2.08	0.69	0.69	6.92	0.69	0.00	2.08
spinal cord, fetal, donor1	10056-101H2	18.90	3.66	3.66	9.76	1.83	3.66	2.44	2.44	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	28.01	9.64	14.24	2.30	4.59	0.00	3.67	4.59	1.38	3.21
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	3.29	0.90	0.90	2.39	0.00	0.90	0.00	0.90	0.30	0.00
spleen, adult, pool1	10025-101D7	42.84	27.20	1.65	1.98	2.64	0.66	1.98	0.66	0.22	0.55
spleen, fetal, pool1	10044-101F8	28.44	13.90	1.99	3.81	0.95	1.51	0.79	0.08	0.08	0.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	43.16	20.18	2.69	1.35	1.14	0.52	0.52	0.31	0.00	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	11.01	4.37	0.38	4.37	0.19	0.95	0.38	0.19	0.19	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	13.63	4.89	0.35	5.94	0.00	0.70	0.70	2.45	2.80	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	29.71	13.68	3.13	2.74	1.17	0.39	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	37.59	13.73	5.63	0.34	1.24	0.34	0.45	0.79	0.79	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	2.97	2.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	8.88	5.50	1.27	1.27	0.42	0.00	0.00	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	10.68	7.48	4.27	5.34	1.07	3.20	3.20	0.00	1.07	1.07
submaxillary gland, adult	10202-103F4	19.37	6.27	2.85	2.85	0.00	1.14	1.71	1.14	1.14	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	54.27	0.00	0.00	0.00	54.27	54.27	0.00
substantia nigra, adult, donor10252	10158-103A5	17.66	5.19	1.66	2.28	2.91	1.66	2.08	1.45	0.83	0.83
substantia nigra, adult, donor10258	10371-105G2	4.66	1.03	4.66	0.52	1.03	0.52	6.72	0.00	0.00	5.69
substantia nigra, newborn, donor10223	10358-105E7	23.32	4.95	5.65	4.95	3.53	0.00	3.53	4.24	0.71	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	11.00	3.21	3.90	24.30	4.81	3.44	0.00	2.52	0.92	0.46
temporal lobe, adult, pool1	10031-101E4	2.54	1.78	0.25	3.65	0.42	0.59	0.59	0.00	0.08	0.34
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	17.81	2.14	7.83	17.81	4.27	3.56	0.71	5.70	0.71	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	14.94	3.52	5.27	16.26	5.71	2.64	1.32	3.08	0.88	0.44
tenocyte, donor1	11763-123H8	4.89	2.09	1.05	1.05	0.00	0.00	0.35	0.00	1.05	0.00
tenocyte, donor2	11765-123I1	2.29	0.38	0.00	0.76	0.00	0.38	0.00	0.00	0.00	0.00
tenocyte, donor3	11768-123I4	1.48	0.37	0.74	0.74	0.37	0.00	0.00	0.74	0.74	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	20.57	7.48	8.16	2.04	2.21	1.36	0.17	0.51	0.34	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	5.24	3.08	2.47	5.55	2.00	1.54	0.00	0.46	0.31	0.00
teratocarcinoma cell line:PA-1	10807-111A6	26.04	12.40	5.27	8.37	1.70	2.79	0.31	1.70	0.15	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	35.29	17.14	13.96	1.02	2.54	0.00	0.51	0.63	0.00	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	29.12	12.86	9.08	0.00	3.78	0.38	0.38	0.00	1.13	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	15.38	7.31	6.00	0.76	2.29	0.44	0.22	0.22	0.22	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	27.03	9.45	24.75	1.63	12.38	0.33	0.00	2.93	1.95	0.33
testis, adult, pool1	10026-101D8	20.83	7.19	3.33	10.09	1.93	4.29	2.25	0.97	0.54	1.40
testis, adult, pool2	10096-102C6	3.61	2.26	0.45	20.30	0.00	8.57	1.35	2.26	0.45	1.35
thalamus - adult, donor10196	10168-103B6	13.25	7.73	5.52	2.21	4.42	0.00	4.42	4.42	1.10	2.21
thalamus, adult, donor10252	10154-103A1	19.38	6.41	3.75	2.97	3.75	0.94	5.94	1.72	0.78	3.28
thalamus, adult, donor10258, tech_rep1	10370-105G1	1.54	4.62	4.62	4.62	0.00	0.00	12.32	0.00	0.00	4.62
thalamus, adult, donor10258, tech_rep2	10370-105G1	3.13	1.81	2.14	1.15	0.49	0.49	2.31	2.80	1.15	1.32
thalamus, newborn, donor10223	10366-105F6	10.93	4.60	4.03	2.88	1.15	0.00	1.73	0.58	2.88	2.30
throat, adult	10209-103G2	29.21	6.99	7.99	2.75	1.50	1.00	4.49	0.50	1.25	2.50
throat, fetal, donor1	10061-101H7	33.52	7.92	3.05	7.01	2.44	2.13	3.96	1.52	2.44	2.44
thymic carcinoma cell line:Ty-82	10803-111A2	0.60	0.20	0.00	0.60	0.00	0.40	0.00	0.20	0.00	0.00
thymus, adult, pool1	10027-101D9	45.83	22.57	4.57	0.60	6.46	0.50	0.50	0.70	0.40	0.10
thymus, fetal, pool1	10043-101F7	69.62	36.26	7.48	3.12	7.17	1.14	0.83	0.52	0.52	1.04
thyroid carcinoma cell line:KHM-5M	10776-110G2	49.73	8.51	9.31	1.46	1.06	0.93	0.13	0.53	0.27	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	18.16	4.61	2.24	2.51	0.70	0.70	0.56	0.42	0.28	0.14
thyroid, adult, pool1	10028-101E1	23.05	7.19	2.05	3.92	2.05	1.40	4.11	0.37	0.28	0.37
thyroid, fetal, donor1	10060-101H6	35.33	6.86	2.64	15.29	1.32	3.69	4.48	5.27	2.11	2.37
tongue epidermis (fungiform papillae), donor1	10288-104F9	3.08	0.00	9.24	3.08	0.00	3.08	3.08	0.00	0.00	0.00
tongue, adult	10203-103F5	25.35	6.05	7.21	2.79	2.09	0.47	3.49	0.23	0.47	3.02
tongue, fetal, donor1	10059-101H5	16.16	3.15	5.12	0.79	1.18	0.39	1.97	0.39	0.39	1.97
tonsil, adult, pool1	10047-101G2	28.75	20.44	2.00	1.40	0.50	0.80	0.50	0.30	0.00	0.20
trachea, adult, pool1	10029-101E2	34.52	10.96	2.45	2.70	0.65	0.90	0.57	0.16	0.16	0.41
trachea, fetal, donor1	10058-101H4	33.08	4.62	6.54	10.00	2.31	1.54	6.54	1.92	0.38	2.69
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	2.48	0.71	0.71	1.42	0.00	1.06	0.00	0.71	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	19.15	7.40	1.62	2.53	0.51	0.51	0.20	0.10	0.10	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	47.63	17.24	7.83	4.54	2.04	2.82	0.47	1.88	0.63	0.63
tridermal teratoma cell line:HGRT	10694-109G1	5.71	0.00	0.00	1.90	0.00	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	20.06	6.60	0.85	1.02	0.42	0.34	0.34	0.08	0.17	0.00
umbilical cord, fetal, donor1	10057-101H3	8.35	0.00	0.00	2.09	0.00	4.17	4.17	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	29.18	7.68	2.39	6.65	1.37	4.44	5.29	0.34	0.00	2.39
uterus, fetal, donor1	10055-101H1	29.69	7.68	4.10	8.70	1.02	4.10	0.51	1.54	1.02	2.05
vagina, adult	10204-103F6	14.22	2.58	1.94	5.17	0.00	0.65	0.65	0.00	0.00	0.00
vein, adult	10191-103E2	29.15	13.15	2.85	2.85	1.53	0.66	1.75	0.00	0.88	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	12.02	5.07	0.80	0.27	0.00	1.34	0.00	0.53	0.27	0.00